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Fast and slow neuronal communication
We navigate through a complicated and demanding environment by using our 
sophisticated ability to perceive and integrate sensory information on a millisecond 
time-scale. This is powered by a fine-tuned network of billions of neurons in our 
brain, which receive, integrate and propagate information. Neuronal communica-
tion relies on the release of fast signaling molecules, neurotransmitters, from 
synaptic vesicles (SVs). In addition virtually all neurons release neuropeptides and 
express a variety of neuropeptide receptors (Smith et al., 2019). Neuropeptides, 
which include neurotrophins and neuromodulators, are slow signaling molecules 
that control neuronal communication. Will a neuron propagate an action poten-
tial, grow a new neurite, or make new connections? Neuropeptides contribute to 
all of these processes. Hereby, neuropeptides significantly alter neuronal circuitry 
output (for review, see Marder, 2012), and contribute to information processing in 
the brain. Neuropeptides are involved in a large variety of physiological conditions, 
such as reward, food intake, learning and memory, social behaviors, reproduction 
and metabolism. Moreover, they are implicated in pathological states, such as 
obesity, addiction, PTSD, autism, depression, and schizophrenia (for reviews, see 
Koob and Volkow, 2010; Meyer-Lindenberg et al., 2011; Schwartz et al., 2000; Tasan 
et al., 2016). Despite their indisputable importance, neuropeptide secretion remains 
understudied and secretory mechanisms are poorly understood. The research pre-
sented in this dissertation aims to contribute to the understanding of the molecular 
mechanisms that underlie the regulated secretion of neuropeptides.
Neuropeptide functions
From an evolutionary perspective, neuropeptides have an early origin and precede 
synaptic neurotransmission (for review, see Grimmelikhuijzen et al., 1999). Neu-
ropeptide precursors are already present in the neuronless organism Trichoplax 
adhaerens (Jékely, 2013), and in lower animals such as corals and sea anemones 
intercellular communication is peptidergic (for review, see Grimmelikhuijzen 
et al., 1996). Neuropeptide signaling is not only ancient, but also highly diverse: 
the term ‘neuropeptides’ denotes a large (>100) group of peptidergic signaling 
molecules, secreted from large dense-core vesicles (DCVs) in mammals (for an 
overview, visit the neuropeptide database www.neuropeptides.nl or see Burbach, 
2011). Neuropeptides typically consist of 3-40 amino acid residues (the product 
of proteolytic processing of larger precursor molecules) and are aggregated into 
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an electron-dense core, after which a DCV is named. Upon release, neuropeptides 
act on a time scale of seconds, which can be partially explained by the fact that 
nearly all neuropeptides engage G-protein coupled receptors (GPCRs) (Hewes and 
Taghert, 2001). Neuropeptides can target multiple GPCRs, e.g., neuropeptide Y 
activates a total of 5 different receptors, each having different kinetics, interactions 
and signaling cascades (for review, see Holliday et al., 2004). The diversity of both 
neuropeptides and neuropeptide receptors affords a large functional diversity, and 
neuropeptide signaling cascades are only beginning to be understood. To illustrate 
their importance, some examples will be highlighted in the following sections.
 Modulators of neurotransmission
One of the most well-known and important actions of neuropeptide signaling, is 
their neuromodulatory action. Neuromodulators do not necessarily transfer an 
excitatory or inhibitory signal from one neuron to another, but rather alter cellular 
and synaptic properties, thereby modulating neurotransmission. For example, 
NPY activates Y2 receptors in the hippocampus, which attenuate the glutamate 
release probability by suppressing Ca2+ influx via N- and P/Q-type Ca2+ channels 
(see for a review Tasan et al., 2016). Lower Ca2+ levels result in a dampened response 
to incoming input. Hereby, NPY substantially reduces neuronal excitability. The 
functional relevance of this mechanism becomes clear during seizures, which lead 
to NPY upregulation (Dubé, 2007). NPY-deficient mice have a kainic acid-induced 
seizure mortality rate of 93%, whereas death is rarely observed in WT littermates 
(Baraban et al., 1997). The phenotype could be fully rescued by pre-exposure to 
NPY (Baraban et al., 1997). Therefore, NPY regulates neuronal excitability, a property 
that is important for survival. This action of NPY is one of many examples where the 
neuromodulatory role of neuropeptides is key for maintaining a healthy excitatory/
inhibitory balance.
Neurotrophic factors
Neurotrophins are implicated in neuronal proliferation, differentiation, survival and 
outgrowth, and include nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), and neurotrophin-3. These neurotrophins act on Trk receptors: TrkA, TrkB and 
TrkC, respectively. BDNF, for example, is known for its role in neuronal development, 
survival and synaptic plasticity (for reviews, see Miranda et al., 2019; Vicario-Abejón et 
al., 2002). Mood disorders, such as major depression, are linked to a reduction in BDNF 
levels and BDNF/TrkB signaling, and treatment with antidepressants increases BDNF 
levels (Nibuya et al., 1995). Moreover, double knockout (DKO) of TrkB receptor subunits 
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Gαi1 and Gαi3 reduces TrkB signaling, dendritic branching, and synapse numbers, and 
induces depressive behaviors in mice (Marshall et al., 2018). These results suggest that 
neurotrophin signaling cascades are essential for maintaining the healthy neuronal 
architecture necessary for promoting mental health.
Long range hormones
Upon release, neuropeptides can act locally or over long distances. Long-range 
signaling may occur in the brain by means of volume transmission (for review, see 
van den Pol, 2012), although the actual distance is under debate (e.g. see Chini et 
al., 2017 for review). Long-range signaling is evident in cases where neuropeptides 
are released into the bloodstream, acting as hormones. One well-studied example of 
a neuropeptide hormone is oxytocin (OXT). OXT is produced in the paraventricular 
nucleus (PVN) and supraoptic nucleus (SON), from which axons project to the pituitary 
to release OXT into the bloodstream to induce labour, among others (Brownstein et al., 
1980). Additionally, OXT acts locally when released in the supraoptic nucleus, where 
it is released during parturition and facilitates its own release via a receptor-mediated 
positive feedback loop (Neumann et al., 1996). Therefore, neuropeptides can act lo-
cally and as long-range hormones depending on their release site.
Protein delivery to cell surface
In addition to vesicle cargo release, DCVs are hypothesized to deliver GPCRs, ion chan-
nels, and other transmembrane proteins to the plasma membrane upon fusion. This is 
supported by the discovery that in dorsal root ganglia at least, the membranes of DCVs 
contain a variety of GPCRs and ion channels (Zhao et al., 2011). Although GPCR sorting 
and delivery has been studied (Hanyaloglu and von Zastrow, 2008), GPCR delivery by 
DCV fusion specifically has not received a lot of attention in the field, and experimental 
evidence is currently sparse.
 Neuropeptides as neurotransmitters
Although the vast majority of neuropeptides act on GPCRs, neuropeptides can 
also act on ionotropic receptors (for review, see DeLaney et al., 2018). For example, 
the invertebrate neuropeptide Phe-Met-Arg-Phe-NH2 (FMRFamide) binds to a 
Na+-gating ion channel, resulting in an inward Na+ current, independent of GPCR 
signaling (Lingueglia et al., 1995). Therefore, neuropeptides can act as transmitter 
molecules that directly contribute to neurotransmission.
There is considerable cross-regulation between neurotransmitters and neuropep-
tides. For example, NPY modulates neurotransmission via presynaptic Y2 receptors, 
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which inhibit release of the neurotransmitter norepinephrine (NE) (see for a review 
Bartfai et al., 1988; Westfall et al., 2006). As NPY requires a stronger stimulation for 
release than NE, this cross-regulation is of physiological significance to put a ceiling 
to NE release at higher frequencies (for review, see Bartfai et al., 1988). In other ex-
amples of cross-regulation, neuropeptides can modulate the affinity or availability 
of neurotransmitter receptors, or inhibit endopeptidases that degrade neuropep-
tides in the extracellular space (for review, see Bartfai et al., 1988). Importantly, 
neurotransmitter/neuropeptide cross-regulation can be a therapeutic target, but 
also a suspect for the side-effects of monoamine antidepressants, such as clozapine 
(for review, see Bartfai et al., 1988).
Neuromodulators and disease
Disruptions in neuropeptide systems are associated with many pathological states, 
such as addiction, stress, major depression, schizophrenia, obesity and anorexia, 
antisocial behaviors and anxiety (for reviews, see Kormos and Gaszner, 2013; Kovac 
and Walker, 2013; Ogren et al., 2010; van den Pol, 2012). Expectedly, several neuro-
peptides receive considerable attention as therapeutic targets, including neuropep-
tide Y to treat PTSD (NIH Clinical Trial ID number NCT01533519), mood disorders 
(NCT00748956) and Type II diabetes mellitus (NCT02639637), and oxytocin as treat-
ment of autism (i.e. NCT01944046, NCT01788072, NCT01908205, NCT01256060), 
alcohol dependence (i.e. NCT03046836, NCT03339024), migraine (NCT01839149), 
depression (i.e. NCT03566069), and many others.
Taken together, neuropeptide actions are diverse, complex, of great physiological 
relevance and are therapeutic targets for a variety of diseases. However, neuropeptides 
remain relatively understudied and their release mechanisms are poorly understood. 
Increasing our knowledge about neuropeptide signaling pathways and release mecha-




An average cultured hippocampal neuron is estimated to contain between 1.400 
– 18.000 DCVs (Persoon et al., 2018). To achieve this, DCVs are de novo synthesized 
at the Golgi. Here, neuropeptide precursor proteins (pre-pro-neuropeptides) are 
sorted and packaged into large DCVs of ~70 nm diameter. Notably, DCVs can also 
contain neurotransmitters and monoamine transmitters, such as acetylcholine 
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(ACh), norepinephrine (NE), dopamine (DA), and serotonin (5-HT) (for review, see 
Merighi, 2018).
DCVs bud from the trans-Golgi network (TGN) as immature organelles (see for a review 
Kim et al., 2006). Maturation of DCVs includes processing of the immature pre-pro-
neuropeptides into one or multiple biologically active neuropeptides by prohormone 
convertases (see Burbach, 2011 for review of cleavage products per precursor). An 
acidic vesicle lumen (pH 5.0-6.0) is required for enzymatic processing, which is accom-
modated by proton pumps in the vesicle membrane, the V/H ATPases (e.g. Helwig 
et al., 2011; Saw et al., 2011). Additional DCV maturation may involve reorganization 
of its membrane. This is supported by the observation that Secretogranin, a DCV 
marker protein, distributes to heavier sucrose fractions over time in density gradients 
of PC12 cell subcellular fractionations, suggesting post-Golgi budding processing 
of DCVs (Tooze et al., 1991). This processing may happen via (1) homotypic fusion, a 
process that may involve Synaptotagmin-4 (Ahras et al., 2006), (2) heterotypic fusion 
with endosomes (Topalidou et al., 2016), and/or (3) clathrin-mediated removal of 
proteins and lipids (for review, see Kim et al., 2006). However, as most experiments are 
performed ex vivo and in non-neuronal cell types, it remains uncertain whether these 
maturation mechanisms occur in (intact) neurons as well.
Trafficking
A hippocampal neuron contains approximately 2-3 DCVs per synapse (Persoon et 
al., 2018). To achieve this, DCVs travel back and forth throughout the axons and 
dendrites along microtubule tracks. This is an energy demanding process, requiring 
ATP hydrolysis for motor proteins such as axonal KIF1A and dynein to conduct an-
terograde and retrograde transport, respectively (for review, see Hoogenraad and 
Akhmanova, 2016; Lo et al., 2011). DCVs that approach a synaptic bouton reduce 
trafficking speed, possibly promoting synaptic capture (Knabbe et al., 2018). The 
continuous flow of DCVs with low-probability capture by synaptic boutons is sug-
gested to ensure an even distribution of vesicles throughout the axon (Wong et al., 
2012), similar to a conveyer belt in a sushi restaurant (for review, see Moughamian 
and Holzbaur, 2012).
Trigger for fusion
A presynapse contains several hundreds of SVs, whereas they contain only a few 
DCVs (Persoon et al., 2018). DCVs often reside outside the active zone, at the pe-
riphery of the synaptic vesicle cluster (Verhage et al., 1991). SVs fuse in response 
to a single action potential. DCV fusion typically requires a stronger physiological 
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trigger, such as a tetanic burst or prolonged high frequency stimulation (Dutton 
and Dyball, 1979; Gainer et al., 1986; Persoon et al., 2018). High-frequency trains of 
action potentials with spaced intervals are most efficient in triggering DCV fusion, 
whereas application of a single action potential does not efficiently trigger DCV fu-
sion (Balkowiec and Katz, 2000; Hartmann et al., 2001; Matsuda et al., 2009; Persoon 
et al., 2018). Related, a single action potential elicits a transient increase in intracel-
lular Ca2+, whereas methods capable of triggering DCVs fusion – high-frequency 
RE
1. de novo synthesis





1. local recycling and relling
3. mild stimulation
4. ion channel coupled
Figure 1: DCV biogenesis and fusion vs. SV recycling and fusion. DCVs differ from SVs with respect to 
their morphology, de novo biogenesis, active axonal and dendritic trafficking, target receptors, and 
required stimulation, as highlighted by the green and orange boxes for DCVs and SVs, respectively.
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burst stimulation, bath application of potassium chloride or ionomycin – increase 
Ca2+ levels for a sustained period of time (Persoon et al., 2018).
In response to intense high-frequency stimulation, only several hundreds of DCVs 
fuse per neuron, which is a small number compared to SV fusion. In addition to a 
smaller DCV pool – a thousand to several thousands per neuron (Persoon et al., 2018), 
the low DCV release numbers may be a consequence of a more distant localization 
from Ca2+ channels compared to SVs. Despite equal distribution among dendrites and 
axons, fusion occurs predominantly in axons (Persoon et al., 2018), where they can 
fuse in- and outside synapses (Wit et al., 2009). In comparison with neurotransmitters, 
relatively few neuropeptides are released. Released neuropeptides are degraded by 
circulating or membrane-bound endopeptidases (Rose et al., 2009). However, neuro-
peptides bind to GPCRs with nanomolar affinities, whereas neurotransmitters bind 
to their ion channels with relatively low affinity (i.e. ~10-100 µM for ACh receptors) 
(Purohit and Grosman, 2006). Therefore, neuropeptides can be potent modulators of 
network activity even at low quantities.
This, together with the above described differences in de novo biogenesis, vesicle 
morphology and cargo, and target receptors, shows that DCV fusion is a fundamen-
tally different mode of neuronal communication than SV fusion (Figure 1).
Cellular Ca2+ gradient and Ca2+ effectors
Neurons invest a considerable amount of energy in the maintenance of a 20.000-
fold Ca2+ gradient across the plasma membrane. This gradient allows cells to use 
transient increases in intracellular Ca2+ as signals to regulate a large range of cellular 
functions, including neurotransmitter and neuropeptide release. A low intracellular 
Ca2+ concentration of 50-100 nM is maintained through Ca2+ cellular ion pumps 
(Ca2+ pumps and Na+/Ca2+-exchangers) (Helmchen et al., 1997; Maravall et al., 2000), 
sequestering free Ca2+ into mitochondria, the endoplasmic reticulum (ER), and in 
lysosomes, and through binding to Ca2+-buffering proteins, such as calmodulin, 
calbindin, calretinin and parvalbumin. Cytosolic Ca2+ can increase through opening 
of voltage-gated Ca2+ channels (VGCCs) and receptor-operated channels with Ca2+ 
permeability, such as N-methyl-D-aspartate receptors (NMDARs) and Ca2+ perme-
able α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPARs). 
Moreover, Ca2+ can enter the cytosol via release of intracellular stores through 
ryanodine receptors and inositol-3-phosphate receptors.
In the presynaptic terminal, Ca2+ levels in close vicinity of Ca2+ channels (10-100 
nm, called a nanodomain), can quickly rise from 50-100 nM to 100 µM after a single 
action potential. Outside the nanodomain, the global Ca2+ levels can increase up 
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to 1.5 µM during a 100 Hz stimulus train (for review, see Neher and Sakaba, 2008). 
The residual Ca2+ concentration, which is Ca2+ remaining after buffering and VGCCs 
closure, is low (10-100 nM) but can remain up to a second, and contributes to short-
term plasticity (for review, see Regehr, 2012).
Ca2+ binding proteins are abundant in the presynapse, and neuronal activity 
activates an array of sensors that trigger downstream signaling pathways. Three 
major classes of calcium sensors are Annexins, EF-hand Ca2+ sensors, and C2 do-
main proteins. Annexins, also known as Lipocortins, possess Ca2+ dependent lipid 
binding domains, and regulate membrane structure. Annexin A2, for example, is 
recruited to membranes upon Ca2+ binding (for review, see Rescher and Gerke, 
2004). Here, it serves as F-actin assembly platform and may stabilize lipid rafts (for 
review, see Rescher and Gerke, 2004). Another group of calcium sensors are the 
EF-hand proteins. EF-hand proteins are involved in a variety of functions, such as 
buffering (e.g. Calbindin) and cell signaling (e.g. Calmodulin) (for review, see Yáñez 
et al., 2012). A particularly large family of Ca2+ sensors is the family of C2-domain 
proteins. In addition to Synaptotagmins, this family includes Protein Kinase C, phos-
pholipase C, Synaptotagmin-like proteins (SLPs), extended Syts (E-Syts), and many 
others. Moreover, C2 domains are present on Munc13 which may facilitate bridging 
of membranes (Brose et al., 1995; Liu et al., 2020), and on CAPS - a vesicle priming 
protein for which the Ca2+ dependent function is currently unknown (for review, see 
Martin, 2015). C2 domains often contain negative aspartate residues that together 
can bind up to three Ca2+ ions (Ubach et al., 1998). Upon Ca2+ binding, some C2 
domains get embedded into negatively charged phospholipids, such as phospha-
tidylserine and phosphatidylinositol, resulting in lipid splaying and membrane 
curvature (for review, see McMahon et al., 2010). The combination of lipid splaying 
and Ca2+ sensing makes C2-domain containing proteins perfect candidates for the 
regulation of membrane fusion. The following sections focus on calcium sensors 
that are directly related to exocytosis: Synaptotagmin (Syt) and Double-C2 domain 
proteins (Doc2).
The fusion machinery
The SNARE complex and Sec/Munc proteins
Fusion of the vesicle membrane with the plasma membrane is an energetically de-
manding process due to the repulsive electrostatic forces between the two membranes 
and other factors, such as water molecules trapped between the two bilayers. Vesicle 
fusion is driven by the coordinate action of a set of proteins, called the fusion machinery. 
Introduction 19
1
The main components of the fusion machinery are Soluble NSF attachment receptor 
(SNARE) proteins. In neurons, SNARE proteins for synchronous SV fusion are SNAP-25, 
VAMP2 and Syntaxin-1 (for reviews, see Jahn and Fasshauer, 2012; Südhof and Roth-
man, 2009), and SNAP-25 and VAMP2 are also identified as regulators of DCV fusion 
(Arora et al., 2017; Hoogstraaten et al., 2020; Shimojo et al., 2015). SNARE proteins form 
a parallel four-helix bundle, which generates energy that is most likely used for fusion 








Figure 2: representation of the molecular machinery for vesicle fusion. The SNARE complex is formed 
by Syntaxin-1 (orange), SNAP-25 (green) and VAMP-2 (red). The SNARE complex is formed with the 
help of priming factor Munc18-1 (light blue) and Munc13-1 (not depicted). Complexin (purple) fa-
cilitates priming and prevents fusion in absence of Ca2+. The two Ca2+ binding domains of Syt-1, C2A 
and C2B, the latter containing a poly-lysine stretch (white pluses), bind to the SNARE complex and 
the plasma membrane upon Ca2+ influx.
The N-terminal region of Syntaxin-1 folds back onto the SNARE motif, thereby prevent-
ing SNARE complex assembly (Dulubova et al., 1999). The Sec/Munc protein Munc18-1, 
as essential docking and priming factor, maintains Syntaxin-1 in its closed conformation 
(Dulubova et al., 1999). Sec/Munc protein Munc13-1 open up Synaxtin-1, and, together 
with Munc18, support SNARE complex assembly (Lai et al., 2017; Ma et al., 2013; Rich-
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mond et al., 2001). Munc13-1 and Munc18-1 furthermore prevent the SNARE complex 
from N-ethylmaleimide sensitive factor (NSF)-mediated disassembly (He et al., 2017a).
Complexin
Complexin is another crucial molecular player in vesicle fusion. Complexin functions 
as a priming factor for SNARE complexes and clamps SNARE complex formation, 
possibly through steric or electrostatic repulsion (Trimbuch et al., 2014). Complexin-
deficient neurons present a similar but milder phenotype as Syt1-KO neurons: loss 
of synchronous SV fusion and increased spontaneous release (Reim et al., 2001). 
For this reason, Complexin’s role is therefore both stimulatory and inhibitory, and is 
regarded as an essential co-factor for Syt1.
Synaptotagmin fusion mechanisms
The fusion to two electrostatically repulsive membranes depends on an increase 
of intracellular calcium (Ca2+), sensed by the calcium sensor Synaptotagmin. Syn-
aptotagmin-1 (Syt1), the first Syt-isoform described (Matthew et al., 1981), is the 
main Ca2+ sensor for synchronous SV fusion (Geppert et al., 1994). Syt1 stimulates 
fusion by the Ca2+ dependent binding to phospholipids and SNARE proteins. Syt1 
is suggested to regulate fusion via several non-mutually exclusive mechanisms. 
First, Ca2+ binding to Syt1 dislodges the Complexin clamp, possibly through a direct 
interaction with the Syt1-SNARE complex, in which Complexin and Syt1 compete 
for SNARE complexes (Tang et al., 2006). Second, Ca2+ binding to the C2 domains 
of Synaptotagmin neutralizes the negative charges between two otherwise elec-
trostatically repulsive membranes, and thereby functions as an ‘electrostatic switch’ 
(Shao et al., 1997; Zhang et al., 1998). Third, Ca2+ binding to the negatively charged 
pockets of the C2 domains allows Synaptotagmin’s Ca2+ binding loops to pertur-
bate the lipid bilayer. Syt thereby bends the plasma membrane (Lynch et al., 2008) 
and creates shear and lowers the energy barrier for fusion. Finally, Syt1 has been 
implicated in linking membranes with its two C2-domains, bringing the vesicle into 
closer vicinity of the plasma membrane (Araç et al., 2006; Chang et al., 2018).
Synaptotagmins
Family members
The coupling of Ca2+ influx to vesicle exocytosis is primarily regulated by Synap-
totagmins. Syts are specialized Ca2+ sensitive proteins that are named after the 
discovery of the synaptic vesicle localization of Syt1, at the time named p65, which 
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is the first Syt paralog described (Matthew et al., 1981). Since then, Syt paralogs 
are found in multicellular organisms (Arabidopsis, Caenorhabditis, Drosophila, Mus, 
Homo, and others) (Craxton, 2004). In mammals, 17 paralogs are described (Craxton, 
2004, 2007), named Syt1-Syt17. Syts are generally characterized by a transmem-
brane domain (TMD) that is flanked by the N-terminal intraluminal fragment, and 
a cytosolic linker of variable length that connects to the Ca2+ binding C2A and C2B 














Figure 3: model of Synaptotagmin-1. Left part represents the SV membrane, in which Syt1 is an-
chored by its transmembrane domain (TMD). The TMD is flanked by the intraluminal fragment and a 
cytosolic linker that connects to the Ca2+ binding C2A and C2B domains. The C2 domains consist of 
two beta-sandwiches of two antiparallel four-stranded beta sheets. The C2A and C2B domain contain 
aspartate residues that form a Ca2+ binding pocket and allow 3 and 2 Ca2+ ions (green dots) to bind, 
respectively. Figure based on crystal structures of C2A and C2B domains (Fernandez et al., 2001; Sut-
ton et al., 1995); linker domains and intraluminal domain are artistic impressions.
Within the C2 domains, Ca2+ is bound to aspartate residues that form a negatively 
charged Ca2+ binding pocket for ~2 or 3 Ca2+ ions to bind. However, of the 17 Syt 
paralogs, about half lack the aspartates that are required for Ca2+- binding: Syt4, 
Syt8, Syt11 – Syt17 (Bhalla et al., 2008; Sugita et al., 2002), broadly dividing the 
Synaptotagmin family into Ca2+-dependent and Ca2+-independent sensors. Of the 
Ca2+ binding Synaptotagmins, Syt1 and Syt2 bind Ca2+ with a considerably lower 
affinity than Syt7, which is considered a high-affinity Ca2+ sensor (Sugita et al., 2002). 
Syt3, Syt5 and Syt10 have intermediate Ca2+ binding affinity, broadly dividing the 
sensors in high, medium and low affinity sensors, although the Ca2+ binding affinity 
also depends on the presence of phospholipids (Sugita et al., 2002). Other classifica-
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tions rely on protein characteristics, such as the presence of disulfide bonds at the 
N-terminus (Syt3, 5, 6, and 10), or N-glycosylation sites at the N-terminus (Syt1 and 
Syt2) (Fukuda et al., 1999; Geppert et al., 1994; Perin et al., 1991).
As Synaptotagmins bind fusion proteins, such as SNARE complexes and Syn-
taxin-1, and to phospholipids, Syts are generally considered a class of membrane 
trafficking proteins (Fernandez et al., 2001; Fernández-Chacón et al., 2001; Li et 
al., 1995). However, to date, the function of most of the Synaptotagmins paralogs 
remains unknown.
Synaptotagmin-1
Ca2+ levels quickly rise and trigger fusion of synaptic vesicles within in a timescale of 
75-100 ms after the action potential (Sabatini and Regehr, 1996), referred to as syn-
chronous SV fusion. Syt1 is the calcium sensor responsible for this ultrafast fusion 
(Geppert et al., 1994), together with Syt2 and Syt9 (Xu et al., 2007). This is consistent 
with its low Ca2+- affinity, which confines Syt1’s Ca2+ binding to the Ca2+ peak of 
the action potential (Sugita et al., 2002). Moreover, Syt1 has fast Ca2+/membrane 
unbinding kinetics, and tight coupling to Ca2+ nanodomains (for reviews, see Eg-
germann et al., 2011; Jackman and Regehr, 2017), further contributing to Syt1’s role 
in synchronous SV fusion.
Syt1 is also required for the fast phase of secretory granule fusion in chromaffin 
cells. As most secretory granule fusion is slow, Syt1 null mutation results in a partial 
effect (~20% reduction) on overall exocytosis (Voets et al., 2001). Taken together, 
Syt1 is generally regarded as a sensor for the fast phase of secretion.
In addition to its role in synchronous/fast fusion, it is well-established that Syt1 
exerts an inhibiting effect on spontaneous, action-potential independent (‘mini’s’) 
release. Spontaneous fusion occurs during stochastic opening of Ca2+ channels or re-
lease from internal stores, resulting in fusion of a single synaptic vesicle. In addition, 
some spontaneous fusion events are probably Ca2+-independent. In Syt1-deficient 
neurons, mini release increases 10-fold, possibly by outcompeting or unclamping of 
another Ca2+ sensor (Maximov and Südhof, 2005; Walter et al., 2011; Xu et al., 2009).
Syt1 deficiency leads to postnatal death in mice within 48 hours (Geppert et al., 
1994). De novo Syt1 missense mutations in the C2B domain in human are linked to sev-
eral neurological/developmental phenotypes, such as severe cognitive impairments, 
severe to profound speech/language impairments, hyperkinetic movement disorder, 




Asynchronous fusion occurs after a longer, variable delay upon the action potential 
(> 10 ms), and can last up to 200 ms (Kaeser and Regehr, 2014)). Under most physi-
ological conditions, asynchronous fusion is absent in most synapses, but becomes 
apparent after repetitive stimulation. However, in some cell types, such as CCK+ 
interneurons, asynchronous release is the primary mode of fusion (Hefft and Jonas, 
2005). Although synchronous release is absent in Syt1-deficient hippocampal neu-
rons, some SV fusion remains, although highly asynchronized (Fig. 4) (Geppert et al., 
1994). Additional ablation of Syt7 in Syt1KO neurons almost completely abolishes 
asynchronous fusion, suggesting Syt7 is the calcium sensor that drives asynchro-
nous SV fusion (Fig. 4) (Bacaj et al., 2013).
Asynchronous fusion mediated by Syt7 becomes apparent in absence of Syt1, or 
after repetitive stimulation (Bacaj et al., 2013; Chen et al., 2017; Luo and Südhof, 
2017; Luo et al., 2015; Turecek and Regehr, 2018; Turecek et al., 2017; Wen et al., 
2010). Syt-7’s role in asynchronous release is in line with its a higher Ca2+ affinity 
(Sugita et al., 2002), allowing Syt7 to bind Ca2+ beyond the peak Ca2+ of an action 
potential. Moreover, Syt7 has exceptionally slow Ca2+ and phospholipid binding 
and unbinding kinetics (Brandt et al., 2012; Hui et al., 2005), characteristics that 
correspond to the role of Syt7 in slower types of vesicle fusion. However, the role 
of Syt7’s extends beyond regulation of asynchronous release. In some synapses, 
Syt7 is required for synaptic facilitation (Jackman et al., 2016), possibly by binding 
residual Ca2+ (for review, see Jackman and Regehr, 2017). Moreover, Syt7 is required 
for SV pool replenishment (Liu et al., 2014). Finally, Syt7 overexpression is able to 
reduce the increase in spontaneous SV release that is observed in Syt1KO neurons 
(Bacaj et al., 2013), suggesting that Syt7 can substitute for Syt1’s clamping func-
tion at increased expression levels. The increase of spontaneous fusion in Syt1KO 
neurons cannot be rescued by knockdown of Syt7, indicating it is not a Ca2+ sensor 
for spontaneous SV fusion under physiological conditions (Bacaj et al., 2013).
Syt7 is also a major calcium sensor for the slow/ phase of neuroendocrine secre-
tion (Schonn et al., 2008). However, loss of Syt7 in Syt1KO cells also reduces the 
fast component of secretory granule fusion with >50%, and therefore also partially 
mediates fast burst of secretory granule exocytosis in chromaffin cells, possibly 
through a role in vesicle priming (Schonn et al., 2008; Tawfik et al., 2020). Moreover, 
Syt7 regulates insulin and glucagon secretion in pancreatic cells (Gao et al., 2000; 
Gauthier et al., 2007; Gustavsson et al., 2008) - the latter phenotype relates to the 
glucose intolerance observed in Syt7KO animals (Gustavsson et al., 2008, 2009). 
Moreover, Syt7 regulates lysosomal fusion in fibroblasts (Martinez et al., 2000, but 
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also see Jaiswal et al., 2004) and likely does so in neurons as well (Padamsey et al., 
2017). Syt7KO animals present inflammation and fibrosis in skin and skeletal muscle 
(Chakrabarti et al., 2003), an effect probably related to the function of lysosomal 
fusion in plasma membrane repair regulated by Syt7 (Reddy et al., 2001).
The changes in neuronal communication in Syt7-deficient neurons, together with 
the disturbed glucose metabolism in Syt7KO animals, may contribute to the manic- 
and depressive-like bipolar behaviors that are observed in Syt7KO mice (Shen et al., 
2020; Wang et al., 2020). This is supported by the reduced expression levels of Syt7 
in both plasma and in IPSC-derived neurons of patients with bipolar disorder (BD), 
and high (~40%) glucose/insulin comorbidities in BD patients (Shen et al., 2020).
Figure 4: evoked exocytosis of SVs in mouse neurons. A) Synchronous evoked response in WT neu-
rons. B) Evoked response in Syt1-KO neurons is desynchronized. C) Syt1KO/Syt7KD neurons abolish 
synchronous and asynchronous exocytosis. D) Spontaneous fusion can be rescued by overexpres-
sion, but not by knockdown of Syt7. Figure adjusted from Bacaj et al., 2013a; Geppert et al., 1994.
Role of Synaptotagmin in fusion pore stability
After fusion pore opening, full fusion pore expansion may lead to complete DCV 
cargo release (‘full fusion’) followed by cargo diffusion in extracellular space (Wit et 
al., 2009). Alternatively, the fusion pore may close, followed by vesicle reacidifica-
tion, resulting in partial cargo release (‘kiss-and-run’). Therefore, fusion pore expan-
sion or re-closure may regulate DCV cargo release.
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The exocytotic fusion pore consists of the mix of membrane lipids and proteins, 
such as SNAREs and Synaptotagmins (Bao et al., 2016). Fusion pore dilation requires 
Syt1 and its interaction with SNAREs, PIPs and Ca2+ (Wu et al., 2019). Mathematical 
modelling suggests that Syt1 Ca2+ binding and membrane insertion reorients the 
SNARE complex in a way that it acts as a lever that increases the fusion pore size (Wu 
et al., 2019). In line with these observations, a Syt1 mutant with a gain-of-function 
for membrane insertion showed increased fusion pore expansion and cargo release 
(Lynch et al., 2008). Summarized, Syt1 requires its membrane interaction to support 
fusion pore dilation and subsequent cargo release.
In PC12 cells, a neuroendocrine cell line, a Syt1 Ca2+ binding mutant reduces 
the amount of secretory granule fusion events, and additionally also shortens the 
event duration of the remaining fusion events (Lynch et al., 2008), suggesting Syt1 
contributes to fusion pore kinetics. Similar conclusions were drawn from patch-
amperometry experiments assessing the pre-spike foot (PSF) duration of secretory 
granule fusion. The pre-spike foot represents a fusion pore that leaks small amounts 
of norepinephrine (NE) prior to full expansion of the fusion pore, generating the 
amperometric spike. Changes in the PSF therefore reflect changes in fusion pore 
stability. A Syt1 mutant with an increased linker length between the C2A and C2B 
domain shortened the PSF duration, suggesting fusion pore stability was reduced 
(Bai et al., 2004a). In line with these observations, overexpression of Syt1 increases 
the PSF (Wang et al., 2001), suggesting pore stability increased. Taken together, 
these experiments suggest that Syt1 promotes fusion pore duration/stability and 
facilitates pore dilation in neuroendocrine cells.
Similar observations have been reported for SV fusion. SV fusion events, reported 
by VGlut1-pHluorin dequenching, are more short-lived in Syt1KO neurons (Li et al., 
2016), possibly reflecting a reduced pore stability. However, the shortened dura-
tion of SV events may also be explained by enhanced endocytosis. Syt1 binds AP-2 
(Zhang et al., 1994), a protein that is essential for clathrin-mediated endocytosis 
(CME) (Boucrot et al., 2010). CME is Ca2+ dependent, but becomes Ca2+-independent 
and slower in Syt1 deficient neurons (Li et al., 2016; Poskanzer et al., 2003) and neu-
roendocrine cells (Yao et al., 2012b). Similarly, Syt1-photoinactivation upon fusion 
slows down endocytosis of SVs, suggesting Syt1 indeed supports endocytosis after 
SV fusion (Poskanzer et al., 2003). This effect seems to oppose Syt1’s role on stabi-
lization on the fusion pore, which prolongs fusion events. However, single vesicle 
fusion event duration and (possibly bulk-) endocytosis are two mechanistically 




Among all Synaptotagmin isoforms, only Syt1, Syt4 and Syt7 are expressed in all 
metazoans (Craxton, 2010). Synaptotagmins are differentially expressed through-
out the brain. Syt1 and Syt7 are relatively abundant in mammals, whereas other 
Synaptotagmins, such as Syt2, Syt9 and Syt10 expression levels are highly restricted. 
Syt8 expression is typically not detected in brain (Figure 5) (Mittelsteadt et al., 2009; 
Zeisel et al., 2015), although some expression may be restricted to hippocampal 
somata (Monterrat et al., 2006). Due to the abundant expression of Syt1 and Syt7 
in brain, their Ca2+-dependent lipid binding capacity and the established roles in 
secretion (as will be discussed below), these sensors are good candidates for DCV 
fusion. Therefore, the following sections primarily focus on these two Ca2+ sensors.
Splice variants
Alternative splicing may in- or exclude specific protein domains. Among all Syt 
paralogs, Syt7 is most extensively alternatively spliced, and at least 8 splice variants 
have been detected in rat ((Craxton and Goedert, 1999; Sugita et al., 2001) Ensembl 
Rat Syt7). Splice variants differ with respect to their linker domain, which separates 
the transmembrane domain from the C2 domains (Figure 6). Exon 5 contains an 
in-frame stop codon, resulting in a truncated splice variant (Syt7T) that lacks the 
C2 domains (Figure 6). The remaining splice variants include the two Ca2+ binding 
domains, but have a variable linker length, resulting in proteins ranging from ~45 
kDa (Syt7S) to ~76 kDa (Syt7L) (Sugita et al., 2001). Long and short splice variants 
of Syt7 are expressed in the brain, whereas insulin secreting and neuroendocrine 
cells mainly express short splice variants (Monterrat et al., 2007; Sugita et al., 2001). 
Alternative splicing of Syt7 is developmentally and regionally regulated; the longer 
isoforms are expressed later in development (during the first postnatal week and 
later), whereas short isoforms are continuously present in the mouse brain (Han et 
al., 2004; Sugita et al., 2001). The role of these splice variants is currently unknown. 
However, Syt7L rescues asynchronous SV fusion in Syt1KD/Syt7KO hippocampal 
neurons (Bacaj et al., 2015), indicating that the longer linker does not interfere with 
its functionality in synaptic transmission. The truncated variant, Syt7T, in contrast, 
does not rescue SV fusion (Bacaj et al., 2015). However, its overexpression slows 
down SV endocytosis ((Li et al., 2016) but also see (Virmani et al., 2003)), but full-
length Syt7 did as well (Li et al., 2016; Virmani et al., 2003), indicating that this effect 
is not specific to the splice variant.
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Syt1, in contrast, has no alternative spliced linker, and only two splice variants are 
reported. Syt1 contains an alternative exon entry that can lead to inclusion or exclu-
sion of three amino acids (‘wobble splicing’) at the juxtamembrane region (McAdam 































Figure 5: Synaptotagmin expression in mouse/rat brain. Overview based on in situ hybridization and 
immunoblot data presented in Marquhze et al.; Mittelsteadt et al., 2009; Roper et al., 2015. The non-
Ca2+ binding Syt13 - Syt17 have been excluded from this overview.
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Cellular localization of Synaptotagmins
Synaptotagmin paralogs differ with respect to their localization. Syt1 is targeted to 
SVs (Brose et al., 1992; Matthew et al., 1981; Takamori et al., 2006), is present on DCVs 
(Walch-Solimena et al., 1993), and travels together with lysosomes (Vukoja et al., 
2018). In contrast, Syt7 is not detected on SVs but instead is present on the plasma 
membrane (Sugita et al., 2001; Takamori et al., 2006). Syt1 and Syt7 are probably both 
localized to secretory granules in neuroendocrine cells, maybe to partially separate 
populations (Rao et al., 2014).
Targeting of Syt1 to SVs depends on an N-terminal N-glycosylation site, which 
is present in Syt1 but not in Syt7 (Han et al., 2004). Substitution of the N-terminal 
sequence of Syt7 with the N-glycosylation sequence of Syt1 is sufficient to target 
Syt7 to vesicular structures in neuroendocrine (PC12) cells. Vice versa, replacement 
of the Syt1 N-terminal sequence for the Syt7 sequence results in plasma membrane 
targeted Syt1 (Han et al., 2004), indicating that the N-terminus regulates Syt target-
5’ 3’1 2 3 4 5 6 7 8 9 10 11 12 13 14403 aa
(Syt7S)
5’ 3’1 2 3 4 5 6 7 8 9 10 11 12 13 14567 aa
5’ 3’1 2 3 4 5 6 7 8 9 10 11 12 13 14520 aa
5’ 3’1 2 3 4 5 6 7 8 9 10 11 12 13 14523 aa
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5’ 3’1 2 3 4 5 6 7 8 9 10 11 12 13 14611 aa
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TMR Alternatively spliced regionStop
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Figure 6: Syt exons and splice variants. Syt1 and Syt7 are alike, but only the linker domain of Syt7 is 
extensively alternatively spliced, resulting in at least 9 slice variants with differential in- or exclusion 
of exons 4-8. Syt7T is a truncated slice variant lacking both C2 domains due to inclusion of exon 5, 
which contains a stop codon. Syt7S is the short splice variants of Syt7, Syt7L the long variant. TMR = 
exon encoding the transmembrane region. C2 domains are localized at the 3’ site (encoding the C-
terminus) and are included in all splice variants with exception of Syt7T. Splice variants adapted from 
Ensembl rat Syt7 (entry number ENSRNOG00000026432).
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ing. Syt1 engineered without a TMD, resulting in a cytosolic C2AB fragment, is still 
functional in liposome fusion assays (Wang et al., 2011). However, expression of 
C2AB in neurons does not restore synchronous SV fusion (Díez-Arazola et al., 2020; 
Lee and Littleton, 2015). In contrast, re-targeting of Syt1 to the plasma membrane by 
replacing the TMD for a palmitoylation sequence of GAP43 fully rescued synchronous 
synaptic vesicle fusion, suggesting Syt1 requires membrane anchoring to mediate 
fusion (Hui et al., 2009; Yao et al., 2012a). However, GAP43-Syt1 does not restore en-
docytosis (Yao et al., 2012a). This suggests that the N-glycosylation site and the TMD 
are required for vesicular targeting and endocytosis, but not for vesicle fusion per se.
Other Ca2+ sensors
Double C2 (Doc2) proteins
Doc2 is a Synaptotagmin-like protein, and possesses two C2 domains that are ho-
mologous to Synaptotagmin. Three isoforms have been reported: Do2α, Doc2β and 
Doc2γ. Of these isoforms, Doc2α and Doc2β bind to phospholipids and to Ca2+ with 
high affinity (Groffen et al., 2010). Doc2γ lacks phospholipid binding, is localized to 
the nucleus (Fukuda and Mikoshiba, 2000; Fukuda et al., 2001), and will not be further 
discussed in this thesis.
Doc2β is abundant in brain, but also expressed in most other tissues, whereas 
Doc2α is exclusively expressed in the brain. Doc2α/β are complementarily expressed 
in brain (Korteweg et al., 2000; Verhage et al., 1997). Both are expressed in the hip-
pocampus (Bacaj et al., 2013; Zeisel et al., 2015). Doc2α/β lack a transmembrane 
domain, resulting in cytosolic localization, but translocate to the plasma membrane 
upon stimulation along with Munc13 (Duncan et al., 1999; Groffen et al., 2004). In 
neurons, Doc2 facilitates spontaneous SV transmission (Courtney et al., 2018; Groffen 
et al., 2010; Pang et al., 2011). It has been suggested that Doc2α and Doc2β regulate 
glutamatergic and GABAergic spontaneous events (mini events), respectively (Court-
ney et al., 2018). However, they are functionally redundant as both isoforms rescue 
inhibitory and excitatory mini’s (Courtney et al., 2018). Additionally, it is reported that 
Doc2α/β regulate asynchronous vesicle fusion in some (Xue et al., 2015; Yao et al., 
2011) but not all studies (Groffen et al., 2010; Pang et al., 2011).
In neuroendocrine cells, Doc2 facilitates priming of adrenal secretory granules (Houy 
et al., 2017). In line with this, Doc2β enhances insulin secretion from MIN6 β-cells (Ke 
et al., 2007) and catecholamine secretion from chromaffin cells (Friedrich et al., 2008). 




In addition to Syt1, two other low affinity Ca2+ sensors, Syt2 and Syt9, mediate syn-
chronous SV fusion in brain stem/cerebellum/striatum and limbic system/striatum, 
respectively (Fernández-Chacón et al., 2001; Geppert et al., 1994; Pang et al., 2006; 
Xu et al., 2007). Although all three mediate synchronous SV fusion, there are differ-
ences in kinetics: Syt2 has a fast onset and decline, whereas Syt9 onset and decline 
is slower (Xu et al., 2007). This fits well Syt2’s expression in synapses that require 
ultrafast signaling, such as the auditory system and neuromuscular junctions.
The role of other sensors remains much more elusive. Syt3 is predominantly 
localized postsynaptically and drives AMPA receptor endocytosis, and Syt3-KO mice 
show impaired LTD and memory extinction (Awasthi et al., 2018). Syt4 negatively 
regulates BDNF (Dean et al., 2009; Wong et al., 2015) and oxytocin release (Zhang 
et al., 2011a), in line with its Ca2+-independency. No function has been described 
for Syt5. Syt6 mediates secretion of endocytosed BDNF-quantum dots, but not 
endogenously produced BDNF (Wong et al., 2015). Syt9, in addition to its role in 
synchronous SV fusion, regulates follicle stimulating hormone (FSH) secretion from 
anterior pituitary cells (Roper et al., 2015), and Syt10 controls insulin-like growth 
factor (IGF-1) secretion in the olfactory bulb (Cao et al., 2011). However, Syt9 and 
Syt10 expression is highly restricted in the brain (Figure 5) (Mittelsteadt et al., 2009; 
Xu et al., 2007; Zeisel et al., 2015). Therefore, the calcium sensors that trigger neuro-
nal DCV fusion remain largely elusive.
AIM AND OUTLINE OF THIS THESIS
Neuropeptides, secreted from DCVs, are essential signaling molecules in brain, 
regulating brain development, neurogenesis and synaptic plasticity. Neuronal 
activity and subsequent rises in Ca2+ levels are essential for DCV fusion. However, 
the molecular machinery that senses Ca2+ and triggers DCV fusion remains unclear. 
The general aim of this thesis is to identify and study the calcium sensors that regu-
late DCV fusion. For this purpose, the effect of genetic ablation of four candidate 
calcium sensors on DCV fusion was investigated in Chapter 2. Syt1 and Syt7 were 
both identified as required, but redundant Ca2+ sensors for DCV fusion. Chapter 3 
focused on the localization of these two sensors in neurons, and reports whether 
Syt1 and Syt7 are present on trafficking and fusing DCVs. In Chapter 4, the kinetics 
of individual fusion events in Syt1 and Syt7 KO neurons were studied. Finally, the 
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main findings of this thesis are summarized and discussed in the light of existing 
literature in Chapter 5.
In Chapter 2, we investigated the role of four candidate calcium sensors on 
DCV fusion, Doc2α/β, Syt1 and Syt7, which were of particular interest due to their 
identified roles in vesicle fusion and their high expression levels in brain. For this 
purpose, DCV fusion was quantified in Doc2α/β, Syt1 and Syt7 null mutant mice. In 
mouse hippocampal neurons, DCV fusion is strongly and equally reduced in Syt1- or 
Syt7-deficient neurons, but combined Syt1/Syt7 deficiency did not reduce fusion 
further, suggesting the two sensors operate in the same pathway. Cross-rescue, 
expression of Syt1 in Syt7-deficient neurons, or vice versa, completely restored 
fusion, indicating redundant functions of these two sensors and suggesting that 
their endogenous expression levels are rate-limiting to compensate for each other’s 
loss. Overexpression of either sensor in WT neurons confirmed this and increased 
fusion. Hence, two calcium sensors together drive neuromodulator secretion in an 
expression-dependent and functionally-redundant manner.
As these results suggest that Syt1 and Syt7 operate in the same pathway, we ad-
dressed the localization of both Syts in Chapter 3. Specifically, we show that Syt1, and to 
lesser extent Syt7, are present on traveling and fusing DCVs. Moreover, Syt7 has a higher 
plasma membrane localization than Syt1. These localization analyses suggest that Syt1 
mediates fusion while being present on the DCV, whereas Syt7 functions elsewhere, 
possibly the plasma membrane.
As both Syts are required for the majority of DCV fusion events, we next tested 
whether Syt1 and Syt7 differentially contribute to the kinetics of fusion events. In 
Chapter 4, the kinetics of individual DCV fusion events in Syt1-KO and Syt7-KO neurons 
were studied and reports that the duration of single DCV fusion events was reduced 
in Syt1-deficient neurons, but not in Syt7-deficient neurons. Syt7 did not rescue event 
duration in Syt1-deficient neurons, suggesting that Syt1 but not Syt7 regulates fusion 
pore stability. Finally, the transmembrane domain of Syt1 is required for fusion pore 
stability, but not for fusion pore opening.
Chapter 5 discusses these findings, provides a model of the molecular mechanism 
of DCV fusion and presents suggestions of future directions for further research.
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Two calcium sensors are required for 
neuromodulator release in neurons in 
a functionally redundant manner
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ABSTRACT
Neuropeptides and neurotrophic factors secreted from dense-core vesicles (DCVs) 
control many brain functions, but the calcium sensors that trigger their secretion 
remain unknown. Here, we show that in mouse hippocampal neurons DCV fusion is 
strongly and equally reduced in Synaptotagmin-1 (Syt1) - or Syt7-deficient neurons, 
but combined Syt1/Syt7 deficiency did not reduce fusion further. Cross-rescue, ex-
pression of Syt1 in Syt7-deficient neurons, or vice versa, completely restored fusion. 
Overexpression of either sensor in WT neurons confirmed this and increased fusion. 
In conclusion, two functionally redundant calcium sensors drive neuromodulator 
secretion in an expression-dependent manner.
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INTRODUCTION
To date, over 100 genes encoding neuropeptides and neurotrophic factors, together 
referred to as neuromodulators, are identified and most neurons express neuro-
modulators and neuromodulator receptors (Smith et al., 2019). Neuromodulators 
travel through neurons in dense core vesicles (DCVs) and upon secretion regulate 
neuronal excitability, synaptic plasticity, and neurite outgrowth (van den Pol, 2012; 
Poo, 2001; Zaben and Gray, 2013). Dysregulation of DCV secretion is linked to many 
brain disorders, including epilepsy, anxiety disorder, and cognitive deficits (Kormos 
and Gaszner, 2013; Kovac and Walker, 2013; Ogren et al., 2010). However, the mo-
lecular mechanisms that regulate neuromodulator secretion remain largely elusive.
Neuromodulator secretion, like neurotransmitter secretion from neurons and 
signaling molecules from neuroendocrine cells, is a tightly controlled process trig-
gered by Ca2+. The Ca2+ sensors that regulate secretion have been described for these 
secretory pathways, but not for neuromodulator secretion. Synaptotagmin (Syt) and 
Doc2a/b are good candidate sensors, due to their interaction with SNARE complexes, 
phospholipids and Ca2+ (Geppert et al., 1994; Li et al., 1995; Perin et al., 1990; Poser 
et al., 1997). The Syt family consists of 17 paralogs (Craxton, 2004, 2007). Eight show 
Ca2+-dependent lipid binding: Syt1-3, Syt5-7, Syt9 and 10 (Bhalla et al., 2008; Sugita et 
al., 2002). Syt1 mediates synchronous fusion of synaptic vesicles (SVs) (Geppert et al., 
1994), consistent with its low Ca2+-dependent lipid affinity (Hui et al., 2005; Sugita et 
al., 2002) and fast Ca2+/membrane dissociation kinetics (Hui et al., 2005; Jackman and 
Regehr, 2017). Syt1 is also required for the fast fusion in chromaffin cells, resulting in 
a partial effect of Syt1 null mutation on overall exocytosis (Voets et al., 2001) and fast 
striatal dopamine release (Banerjee et al., 2020). Synaptotagmin-7 (Syt7), in contrast, 
drives asynchronous SV fusion (Bacaj et al., 2013), in line with its a higher Ca2+ affinity 
(Sugita et al., 2002) and slower dissociation kinetics (Hui et al., 2005). Syt7 is also a major 
calcium sensor for neuroendocrine secretion (Schonn et al., 2008), and for insulin and 
glucagon secretion in pancreatic cells (Gao et al., 2000; Gauthier et al., 2007; Gustavs-
son et al., 2008). Other sensors include Syt4, which negatively regulates BDNF (Dean et 
al., 2009) and oxytocin release (Zhang et al., 2011a), in line with its Ca2+-independency. 
Syt9 regulates follicle stimulating hormone secretion in anterior pituitary (Roper et al., 
2015) and, together with Syt1, secretion from PC12 cells (Fukuda et al., 2002; Lynch 
and Martin, 2007). Syt10 controls insulin-like growth factor secretion (Cao et al., 2011). 
However, Syt9 and Syt10 expression is highly restricted in the brain (Mittelsteadt et 
al., 2009; Xu et al., 2007; Zeisel et al., 2015). Hence, the calcium sensors for neuronal 
DCV fusion remain largely elusive. Because DCVs are generally not located close to 
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Ca2+ channels (Persoon et al., 2018), we hypothesized that DCV fusion is triggered by 
high affinity Ca2+ sensors. Due to their important roles in vesicle secretion, their Ca2+ 
binding ability, and high expression levels in brain (Bacaj et al., 2013; Groffen et al., 
2010; Mittelsteadt et al., 2009; Pang et al., 2011; Verhage et al., 1997; Yao et al., 2011), 
we addressed the roles of Doc2a/b, Syt1 and Syt7 in neuronal DCV fusion.
In this study, we used primary hippocampal Doc2a/b-, Syt1- and Syt7-null (KO) neu-
rons expressing a DCV fusion reporter (Bospoort et al., 2012; Emperador-Melero et al., 
2018; Persoon et al., 2018; Wit et al., 2009) to obtain real-time single-vesicle resolution of 
DCV fusion events. We show that both Syt1 and Syt7, but not Doc2a/b, are required for 
~60-90% of DCV fusion events. Deficiency of both Syt1 and Syt7 did not produce an ad-
ditive effect, suggesting that both Syts function in the same pathway. Overexpression 
of Syt1 (Syt1-OE) rescued DCV fusion in Syt7-null mutant neurons, and vice versa, indi-
cating that the two proteins compensate for each other in the DCV secretory pathway. 
Moreover, overexpression of Syt1 or Syt7 in WT neurons increased DCV fusion rates, 
suggesting that the two Syts are rate-limiting for DCV fusion. We conclude that DCV 
fusion requires two calcium sensors, Syt1 and Syt7, that act in a single/serial pathway, 
and that both sensors regulate fusion in a rate-limiting and dose-dependent manner.
RESULTS
Doc2a/b are dispensable for DCV fusion
To identify the calcium sensor(s) for DCV fusion in neurons, we used single hippo-
campal neurons cultured on glia micro-islands expressing the DCV fusion reporter 
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Figure 1: experimental protocol.
a. Stimulation paradigm with a single vesicle fluorescence intensity trace.
b. Large image: representative image of NPY-SEP infected neuron during Tyrode’s-NH4 application. 
Scale bar = 20 µm. Zoom: neurite before (baseline) and during (16x50AP at 50 Hz) stimulation and 
during NH4 application (NH4). Scale bar = 10 µm.
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NPY-Super Ecliptic pHluorin (SEP) (Fig.1A, B) to quantify DCV fusion at single-vesicle 
resolution (Bospoort et al., 2012; Emperador-Melero et al., 2018; Persoon et al., 
2018). Vesicle fusion was triggered by bursts of action potentials at 50 Hz (Fig.1A). 
The total number of DCVs per neuron was quantified upon brief NH4 superfusion to 
dequench NPY-SEP in all acidic compartments (DCVs, Fig.1A, 1B).
Doc2a/b are soluble high-affinity calcium sensors reported to trigger spontaneous and 
asynchronous SV fusion (Groffen et al., 2010; Pang et al., 2011; Yao et al., 2011). Due to 






































































































Figure 2. DOC2a/b DKO does not affect DCV fusion
a. Median number of neuropeptide vesicle fusion events in control (DHZ), and Doc2a/b DKO neurons 
in a cumulative plot (nHZHZ=13, nDKO=14).
b. Normalized median cumulative fusion of DCVs per neuron in control and DKO neurons.
c. Normalized median cumulative DCV fusion event duration per neuron in control and DKO neu-
rons.
d. Total number of DCVs per neuron is not significantly different between control and DKO neurons 
(Mann Whitney U = 67, p = .26).
e. Fusing fraction in control and DKO neurons is similar (Mann Whitney U = 91.0, p > .99).
f. Fusion timing in control and DKO neurons is not significantly different (t(25) = 48.6, p = 0.63).
Number before and after dash represents number of independent experiments and number of neu-
rons, respectively.
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et al., 2006), we hypothesized that Doc2a/b are suitable Ca2+-sensors for DCV fusion. To 
test this, DCV fusion was quantified in Doc2a/b double-null (DKO) neurons and double-
heterozygous (DHZ) littermate controls (nHZHZ=13, nDKO=14). DCV fusion upon high 
frequency stimulation, visualized by rapid dequenching of NPY-SEP puncta (Figure 1A, B, 
Fig. S1A), was abundant in DHZ neurons, and occurred almost exclusively during stimula-
tion (Figure 2A). Doc2a/b deficiency did not alter the number of DCV fusion events nor 
the total number of DCVs per neuron (Figure 2A, D). In line with these findings, the 
released fraction of DCVs, defined as the number of fusing vesicles divided by the total 
DCV pool, was not affected by Doc2a/n deficiency (Figure 2E). Moreover, no difference in 
fusion kinetics, either timing or event duration, was observed (Figure 2B, C, F).
DCV fusion requires both Syt1 and Syt7
Due to their established roles in synaptic- and neuroendocrine vesicle secretion, and 
high brain expression levels (Bacaj et al., 2013; Mittelsteadt et al., 2009; Zeisel et al., 
2015), we next tested the role of Syt1 and Syt7 in DCV fusion using Syt1 knock-down 
(Syt1-KD, (Xu et al., 2012)), Syt7-null mutant (Syt7-KO, (Maximov et al., 2008)), and 
Syt1-KD/Syt7-KO hippocampal neurons. Immunoblotting of Syt1 from hippocampal 
cultures confirmed Syt1-KD efficiency in Syt1-KD neurons, as shown before (Supple-
mentary Figure 1B, (Xu et al., 2012)). Wild-type (WT) neurons showed many fusion 






























































Figure 3. Synaptotagmin-1 and Synaptotagmin-7 are required for neuropeptide vesicle fusion.
a. Median number of neuropeptide vesicle fusion events per neuron in a cumulative plot in Syt1-KD, 
Syt7-KO and Syt1-KD/Syt7-KO neurons, respectively.
b. Box plot of fusing fraction (X2(4) = 14.05, p = .0028), defined as the number of fusion events divided 
by total number of vesicles per neuron measured during Tyrode’s-NH4 superfusion.
c. Deficiency of Syt1 or Syt7 does not affect the total number of DCVs per neuron (X2(4) = 1.233, p = .75).
Median value is presented in or next to the box plot. Number before and after dash represents num-
ber of independent experiments and number of neurons, respectively. *p < .05, **p < .01, ns p>.05.
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neurons the number of DCV fusion events was reduced by 64% and 69%, respectively 
(Figure 3A, Supplementary Figure 1D). Strikingly, loss of both Syt1 and Syt7 did not 
produce additive effects, but a similar reduction in fusion events (76% reduction) 
as in single mutant neurons (Figure 3A, Supplementary Figure 1D). The absence of 
Syt1 and/or Syt7 did not significantly alter the timing of the remaining DCV fusion 
events (Supplementary Figure 1E, F), or the total number of DCVs per neuron (Fig. 
3B). The released fraction, defined as the number of fusing vesicles divided by the 
total DCV pool, showed a 3-fold reduction in Syt1-KD, Syt7-KO and Syt1-KD/Syt7-KO 
neurons (Supplementary Figure 3C). Hence, DCV fusion in hippocampal neurons 
requires both Syt1 and Syt7, and loss of both sensors does not produce additive 
effects, suggesting that the two sensors function in a single pathway. 
Syt1 and Syt7 cross-rescue DCV fusion
We next asked whether Syt1 and Syt7 are essential for DCV fusion, or whether the 
absence of one sensor can be by-passed by overexpressing the other (‘cross-rescue’). 
To test this, Syt1 or Syt7 was overexpressed in Syt7-KO or Syt1 null mutant (Syt1-KO) 
(Geppert et al., 1994) neurons, respectively.
We first confirmed that in Syt1-KO neurons DCV fusion was reduced to a similar 
extent as in Syt1-KD neurons (Figure 4A). Furthermore, Syt1 expression in Syt1-KO 
neurons fully rescued DCV fusion, as well as the released fraction (Figure 4A, B). 
Strikingly, over-expression of Syt7 in Syt1-KO neurons also rescued DCV fusion 
(Figure 4C) and fusing fraction (Figure 4D) similar to Syt1 expression in Syt1-KO 
neurons. Conversely, overexpression of Syt1 in Syt7-KO neurons also rescued DCV 
fusion event numbers and fusing fraction (Figure 4E, F), to a comparable extent as 
Syt7 rescue (Figure 4E, F). Cross-expression of either Syt1 or Syt7 did not affect the 
total number of DCVs nor fusion timing (Supplementary Figure 2A-C). Hence, Syt1 
and Syt7 are functionally redundant in supporting DCV fusion upon overexpression.
Fusion timing, defined as the latency to fusion onset relative to the onset of stimula-
tion, was not significantly different between all groups tested (Supplementary Figure 
1). However, small changes in fusion timing may occur in the initial phase of the 
stimulation. To test this, we compared the percentage of vesicles that fused during the 
first 50 AP, or during the first 150 AP, and found no difference between groups of either 
condition (Supplementary Figure 3A-C and D-F, respectively). The number of fusion 
events after the end of the stimulation burst was also compared. While the absolute 
number of fusion events was severely reduced in Syt1KO neurons (Fig. 3, Fig. 4), the 
relative number of delayed fusion events, after the end of the stimulation, was also not 
significantly different (Supplementary Figure 4A-F). Hence, Syt1 and Syt7 do not affect 





























































































































Figure 4: Synaptotagmin-1 and Synaptotagmin-7 can cross-rescue neuropeptide vesicle fusion.
a. Median number of neuropeptide vesicle fusion events in WT, and Syt1-KO neurons with 
and without Syt1-OE in a cumulative plot.
b. Fusing fraction in Syt1-KO neurons is rescued by Syt1-OE (X2(3) = 19.28, p < .0001). For len-
tiviral infection, 2 µl of lentivirus was used. For the effects of different volumes of lentivirus, 
see Supplementary Figure 5.
c, d. Same as A-C, but with Syt7-OE. Fusing fraction in Syt1-KO neurons is rescued by Syt7-OE 
(X2(3) = 20.96, p < .0001).
e, f. Same as A-C, but with Syt7-KO neurons with Syt7-OE. Fusing fraction in Syt7-KO neurons 
is rescued by Syt7-OE and Syt1-OE (X2(4) = 15.96, p = .0012). Median value is presented in 
or next to the box plot. Number before and after dash represents number of independent 
experiments and number of neurons, respectively. *p < .05, **p < .01, ***p < .001, ns p>.05.
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Overexpression of Syt1 and Syt7 in WT neurons increases DCV fusion
Because excess of Syt1 cross-rescued Syt7-deficient neurons, and vice versa, (Fig. 
4), whereas physiological levels were not sufficient (Fig. 3), we conclude that en-
dogenous Syt levels are rate-limiting in their regulation of DCV fusion. To confirm 
this, Syt1 and Syt7 were overexpressed in WT neurons. Overexpression resulted in 
a 50% and 100% increase in Syt1 and Syt7 immunostaining intensity, respectively, 
without affecting the expression of the other sensor (Supplementary Fig. 6C, D). 
Total DCV pool sizes were unaffected (Fig. S6A, B). Overexpressing Syt1 (Figure 5A, 











































































Figure 5: Overexpression of Syt1-OE and Syt7-OE in WT neurons increases neuropeptide vesicle fusion.
a. Median number of neuropeptide vesicle fusion events in WT neurons with and without Syt1-OE 
in a cumulative plot.
b. Fusing fraction is increased in WT neurons with Syt1-OE (U = 193, p < .05). Neurons with a fusing 
fraction above 0.9 were plotted at 0.9 for visualization purposes. 
c, d Same as a, b, but with Syt7-OE (Fusing fraction U = 174, p < .05). Median value is presented in or 
next to the box plot. Number before and after dash represents number of independent experi-
























































































































































Figure 6. Caption on next page ⇢
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significantly increased DCV fusion 2-fold and 1.5-fold, respectively. Additionally, 
both Syt1-OE and Syt7-OE increased the fraction of fused DCVs (Figure 5B, D). These 
data suggest that endogenous levels of Syt1 and Syt7 are rate-limiting for DCV fu-
sion in neurons.
DCV fusion requires the Ca2+-binding capacity of Syt1- and Syt7
To confirm whether Syt1 and Syt7 are indeed Ca2+ sensors for DCV fusion, we ex-
pressed Syt1 and Syt7 variants that cannot bind Ca2+ (Syt1-DA and Syt7-DA (Bacaj et 
al., 2013)) in Syt1KO or Syt7KO neurons. Overexpression of Syt1-DA and Syt7-DA did 
not restore DCV fusion (Fig. 6A, B, E, F) in Syt1KO or Syt7KO neurons, respectively. 
Similarly, the shorter event duration observed in Syt1-KO neurons was not rescued 
by overexpression of Syt1-DA (Fig. 6C, D). These data suggest that Ca2+ binding is 
indeed required for Syt1/7-dependent DCV fusion and both Syt1 and Syt7 are main 
Ca2+-sensors for DCV fusion.
DISCUSSION
Calcium sensors have been identified for fusion of SVs (Bacaj et al., 2013; Geppert et 
al., 1994), lysosomes (Martinez et al., 2000), secretory granules in pancreatic α- and 
β-cells (Gao et al., 2000; Gauthier et al., 2007; Gustavsson et al., 2009; Iezzi et al., 
Figure 6. Syt1- and Syt7-mediated DCV fusion require Ca2+-binding
a. Median number of neuropeptide vesicle fusion events in WT and Syt1-KO neurons with and with-
out Syt1-DA expression in a cumulative plot. See Fig. 4A,B for Syt1-KO neurons rescued with Syt1.
b. Fusing fraction in Syt1-KO neurons is not rescued by Syt1-DA expression (X2(3) = 25.01, p < .0001).
c. Normalized cumulative median event duration per neuron in WT, Syt1-KO and Syt1-KO neurons 
with Syt1-DA expression.
d. Event duration in Syt1-KO neurons is not rescued by Syt1-DA expression (X2(3) = 15.29, p = .0005).
e. Median number of neuropeptide vesicle fusion events in WT and Syt7-KO neurons with and with-
out Syt7-DA expression in a cumulative plot. See Fig. 4E,F for Syt7-KO neurons rescued with Syt7.
f. Fusing fraction in Syt7-KO neurons is not rescued by Syt7-DA expression (X2(3) = 28.23, p < .0001).
g. Normalized cumulative median event duration per neuron in WT, Syt1-KO and Syt1-KO neurons 
with Syt1-DA expression.
h. Event duration in Syt7-KO neurons with and without Syt7-DA expression is not significantly differ-
ent from WT neurons (X2(3) = 2.94, p = .23).
Box plots are plotted with 25% (Q1) and 75% (Q3) interquartile range and Tukey whiskers. Num-
ber before and after dash represents number of independent experiments and number of neurons, 
respectively. Please note that the difference in n-numbers between release probability and fusion 
duration originates from non-releasing neurons having no event duration. * p <.05, ** p < .01, ***p < 
.001, ****p < .0001 ns p > .05.
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2004), and in neuroendocrine cells (Schonn et al., 2008; Voets et al., 2001). However, 
the calcium sensors responsible for neuromodulator release in neurons have re-
mained largely unknown. In this study, we show that Syt1 or Syt7 deficiency, but not 
DOC2A/B deficiency, each reduced DCV fusion by 60-90% in hippocampal neurons 
(Fig. 2A, E, 3A, B, 4A-F, 6A, B, E, F). Syt1 or Syt7 deficiency did not selectively affect 
specific components of DCV fusion (Fig. S2D-F, S3A-F, S4), affected fusion equally 
(Fig. 3A, C) and did not produce an additive effect (Fig. 3C, Supplementary Figure 
1D). This indicates that, in hippocampal neurons, Syt1 and Syt7 together drive fu-
sion of the same vesicle pool with the same kinetics in a single secretory pathway. 
Overexpression of Syt1 in Syt7-KO or Syt7 in Syt1-KO neurons cross-rescued DCV 
fusion (Fig. 4A-F), indicating that the two proteins compensate for each other in the 
secretory pathway. Overexpression of Syt1 or Syt7 in WT neurons increased DCV 
fusion by 2-fold and 1.5-fold, respectively (Fig. 5), suggesting that both proteins are 
rate-limiting for DCV fusion.
Loss of Syt1 or Syt7 expression led to the loss of most DCV fusion events (60-90% 
reduction). However, due to the mixed nature of hippocampal cultures, this effect 
may still be an underestimation. A small fraction of hippocampal neurons expresses 
Syt2 (García-Junco-Clemente et al., 2010), or Syt9 (Dean et al., 2012; Mittelsteadt et 
al., 2009; Xu et al., 2007). These paralogs also bind Ca2+ and have similar properties 
as Syt1 and Syt7 and may therefore compensate for the loss of Syt1 or Syt7 expres-
sion in a fraction of neurons in our cultures. Consistent with this, we observed that 
a small subset of neurons still released many DCVs in the absence of Syt1 and/or 
Syt7 (Supplementary Figure 1D). Hence, the true importance of Syt1 and Syt7 for 
neuromodulator release in most neurons may still be partially masked by expres-
sion of other Ca2+ sensors in a few other neurons.
Syt1 or Syt7 deficiency did not selectively affect DCV fusion timing (Supple-
mentary Figure 2D-F, 3A-F, 4A-G), affected fusion equally (Fig. 3A, C, Fig. 4A-F) and 
deficiency of both did not produce additive effects (Fig. 3). This indicates that in 
hippocampal neurons Syt1 and Syt7 together drive fusion of the same vesicle pool 
with the same kinetics in a single secretory pathway. This situation is very differ-
ent from the best studied systems so far, where sensors have specialized functions 
and drive fusion of distinct release phases: Syt1 drives synchronous SV fusion in 
neurons and fast secretory granule fusion in chromaffin cells, while Syt7 primar-
ily drives asynchronous and slow fusion in these two systems (Bacaj et al., 2013; 
Geppert et al., 1994; Schonn et al., 2008; Voets et al., 2001), and may be involved in 
vesicle priming (Bacaj et al., 2013; Schonn et al., 2008) and activity-dependent pool 
replenishment (Liu et al., 2014). Syt7 overexpression does not restore (Syt1-driven) 
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synchronous SV release in Syt1-KO neurons (Bacaj et al., 2013) and combined defi-
ciency of Syt1 and Syt7 reduces both phases, producing clear additive effects (Bacaj 
et al., 2013; Schonn et al., 2008). Hence, while Syt1 and Syt7 have clearly specialized 
functions in SV and chromaffin granule exocytosis, they do not for DCVs. This may 
be explained by evolutionary adaptations, optimizing chromaffin granule and SV 
exocytosis for fast and ultrafast kinetics, respectively, while there may not be an 
evolutionary advantage for optimizing neuromodulator signaling further. Syt1 and 
Syt7 most likely emerged by gene duplication of an ancestral Syt. Our data suggest 
that this duplication happened first, making secretory pathways more efficient and 
stimulus-dependent, and that Syt1 and Syt7 subsequently became more special-
ized to drive different phases of fast or ultrafast vesicle fusion in highly specialized 
secretory pathways, but not in the DCV pathway.
Although Syt1 and Syt7 have specialized functions in synaptic transmission, but 
not in the DCV secretory pathway, the two sensors appear to act on a single pool 
of vesicles in both situations. Functional redundancy among Syts has been shown 
for the maintenance of the readily releasable vesicle pool (Bacaj et al., 2015), and 
Syt7 overexpression inhibits the increase of spontaneous SV fusion in Syt1-deficient 
neurons (Bacaj et al., 2013). Hence, with or without specialized functions, the two 
sensors do not act in parallel pathways, but drive fusion of a single pool of vesicles 
in a single pathway for SVs and DCVs alike.
Syt1 and Syt7 were shown to act as redundant Ca2+-sensors for Ca2+-dependent 
AMPA receptor exocytosis during the induction of long-term potentiation (Wu et 
al., 2017a). While loss of either Syt1 or Syt7 was sufficient to lose most DCV fusion 
events (Fig. 3A, C, Fig. 4A-F, Supplementary fig. 5D-H), AMPA receptor insertion was 
lost only after losing both (Wu et al., 2017a). Hence, native Syt1/7 expression levels 
are probably more rate limiting for DCV fusion than for AMPA receptor insertion, 
as WT neurons do not express enough of one Syt to compensate for the loss of the 
other in single null mutant neurons (Fig. 3C). This conclusion is further supported 
by the fact that either Syt1 or Syt7 overexpression produced substantial increase in 
DCV fusion in WT neurons (Fig. 5A-D).
Syt1 mRNA levels were not affected after Syt7KD, nor did Syt1 levels differ be-
tween Syt7 null mutant neurons with and without Syt7 overexpression (Bacaj et al., 
2013), suggesting neurons do not compensate for the loss of one sensor by increas-
ing expression of the other. Similarly, WT neurons overexpressing either Syt did not 
result in altered expression of the other (Fig. S6C, D). Because Syt1 and Syt7 cellular 
expression levels are rate-limiting for DCV fusion (Fig. 5A-D), at least in hippocampal 
46 Chapter 2
neurons, transcription regulation of either of the two genes may be a powerful way 
to regulate neuromodulation.
Neuromodulator signaling is a slow process relative to synaptic transmission 
and DCV fusion requires prolonged stimulation with very few DCVs fusing upon 
single action potential stimulation (Persoon et al., 2018) and during the onset of 
high frequency stimulation (Supplementary Figure 3A-C). The key determinants of 
these slow kinetics remain incompletely understood, but one relevant observation 
is that DCVs, unlike SVs, do not typically cluster at the active zone (Bospoort et al., 
2012; Imig et al., 2014), where Ca2+-channel accumulation produces rapid local Ca2+-
transients (Llinás et al., 1992; Zucker and Fogelson, 1986). Hence, it will take longer 
before Ca2+-transients spread through the terminal or axon and activate Ca2+-sen-
sors on DCVs. Since Syt1 is among the Ca2+-sensors with the lowest Ca2+-sensitivity 
(Sugita et al., 2002), Ca2+ must rise to high micromolar level before this sensor is 
activated. This reasoning contributes to an explanation for the slow DCV-release 
onset. However, previous studies indicate a considerable delay between the peak 
of (bulk) Ca2+-increase in axons and the onset of DCV fusion (Persoon et al., 2018). 
Therefore, additional factors probably contribute to the slow DCV-release onset. For 
instance, DCVs are transported through neurites on molecular motor complexes 
(kinesins, dyneins, (Hoogenraad and Akhmanova, 2016; Lo et al., 2011)) and may 
need time to dissociate from these motors and translocate to a fusion site (Bharat et 
al., 2017; Stucchi et al., 2018).
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Supplementary Figure 1: Syt1 protein levels in Syt1-KD neurons, and DCV fusion in Syt1-KD, Syt7-
KO and Syt1-KD/Syt7-KO neurons.
a. Representative examples of NPY-SEP fluorescence traces. Blue shading represents stimulation of 
16 x 50 AP at 50 Hz. Green shadings represent NH4 bath application. Green lines are example fluo-
rescence traces of single DCV fusion events.
b. Syt1-KD efficiently reduces Syt1 protein levels. Upper lanes: WT and Syt1-KD neurons blotted for 
Syt1. Lower lanes: WT and Syt1-KD neurons blotted for GAPDH as loading control.
c. Quantification of Syt1 protein levels in WT and Syt1-KD neurons.
d. Number of DCV fusion events per neuron is significantly reduced in absence of Syt1 and/or Syt7 
(X2(4) = 11.69, p = .01). Box plots are plotted with 25% (Q1) and 75% (Q3) interquartile range and 
Tukey whiskers. Numbers before and after dash represents number of independent experiments 
and number of neurons, respectively.
e. Normalized median cumulative fusion of DCVs per neuron.
f. Mean timing of DCV fusion events per neuron (F(3,88) = .80, p = .50).
Bar plots are plotted as mean ± SEM. ns = p > .05, *p < .05, **p < .01.













































































































































































































Supplementary Figure 2: DCV pool sizes and fusion timing of (cross-)rescued neurons
a. Total number of DCVs present in a neuron (pool size) is not different between WT, Syt1-KO and 
Syt1-KO with Syt1-OE. (X2(3) = 4.59, p = .10).
b. Same as a, but with Syt7-OE (X2(3) = 2.02, p = .36)
c. Same as a and b, but with Syt7-KO neurons overexpressing Syt7 or Syt1 (X2(4) = 10.31, p = .05).
d. Median timing of DCV fusion events per neuron (X2(3) = 5.65, p = .06).
e. Median timing of DCV fusion events per neuron (F(2, 57) = 1.435, p = .25).
f. Median timing of DCV fusion events per neuron (F(3, 65) = 1.294, p = .28).
50 Chapter 2
Percentage of fusing fractions in first burst





































































































































































Supplementary Figure 3: Percentage of fusing fraction that occurs in the early phase of stimulation 
is not affected.
a, b, c. The percentage of the fusing fraction that fuses in the first 50 AP (first burst) of stimulation is 
unaffected between genotypes (X2(3) = 1.891, p = .38; X2(3) = 0.547, p = .76; F (4, 80) = 0.8177, 
p = .52, respectively).
d, e, f. The percentage of the fusing fraction that fuses in the first 150 AP (3 bursts of 50 AP) of stimu-
lation is unaffected between genotypes (X2(3) = 3.655, p = .17; X2(3) = 1.296, p = .52; F (4, 80) 
= 0.4299, p = .79, respectively)












































































































































Supplementary Figure 4: Fusing fraction after stimulation
a. Fusing fraction of events that fuse after the 16 x 50 AP stimulation bursts is not significantly differ-
ent in Syt1-KD neurons compared to Syt1-KD/Syt7-KO neurons (X2(4) = 5.29, p = .15).
b. The relative amount of fusion (fraction of fusion events after stimulation / total fusing fraction) is 
not significant different (X2(4) = 3.34, p = .34).
c. Fusing fraction of events that fuse after the 16 x 50 AP stimulation bursts is significantly reduced in 
Syt1-KO neurons compared to Syt1-KO + Syt1 neurons (X2(3) = 7.64, p = .022).
d. The relative amount of fusion is not significantly higher in Syt1-KO neurons compared to WT neu-
rons (X2(3) = 5.4, p = .07).
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e. Fusing fraction of events that fuse after the 16 x 50 AP stimulation bursts is significantly reduced in 
Syt1-KO neurons compared to WT and Syt1-KO + Syt7 neurons (X2(3) = 12.65, p = .0018).
f. The relative amount of fusion is not significant different (X2(3) = 2.643, p = .27).
g. Fusing fraction of events that fuse after the 16 x 50 AP stimulation bursts is significantly different 
between WT and Syt7-KO (X2(4) = 10.22, p = .017).
h. The relative amount of fusion is not significant different (X2(4) = 3.969, p = .026).
⇢
Supplementary Figure  5: DCV fusion and DCV event duration in neurons infected with variable 
amounts of Syt1-expressing lentivirus. 
a. Representative images of WT and Syt1-KO neurons infected with variable amounts of Syt1-ex-
pressing lentivirus, immunostained for Syt1 (red) and VGluT1 (green). Scale bar = 10 µm.
b. Syt1 intensity in neurons. Multiple comparisons to WT neurons shown exclusively for clarity pur-
poses (F(7,82) =25.66, p < .0001). Numbers of neurons included in analyses: nWT = 13 ; nKO = 9; nKO 
+ 0.5 µl = 8; nKO + 1 µl = 10; nKO + 1.5 µl = 13; nKO + 2 µl = 14; nKO + 3 µl = 12; nKO + 4 µl = 11 .
c. Syt1 intensity in VGluT1+ synapses. Multiple comparisons to WT neurons shown exclusively for 
clarity purposes (F(7,82) = 24.22, p < .0001). Number of neurons equal to panel b.
d. Median number of neuropeptide vesicle fusion events in WT and Syt1-KO neurons with and 
without different volumes of Syt1 expression in a cumulative plot.
e. Event duration of DCV fusion events in WT and Syt1-KO neurons with and without different vol-
umes of Syt1 expression in a normalized cumulative plot.
f, g. Same as D, but with higher amounts of lentivirus. Note that data presented in Fig D-E and F-G 
are gathered in a single experiment, distributed over two panels, presenting the WT data twice. 
Panels were splitted for clarity purposes.
h. Number of DCV fusion events per neuron. All volumes significantly increase DCV fusion (X2(8) = 
32.88, p < .0001).
i. Median event duration in WT and Syt1-KO neurons with and without different volumes of Syt1 
expression (X2(8) = 22.84, p = .0018).


























































































Syt1-KO + Syt1 (1.5 µl)
Syt1-KO + Syt1 (1.0 µl)
Syt1-KO + Syt1 (0.5 µl)
Syt1-KO
Syt1-KO + Syt1 (4.0 µl)
Syt1-KO + Syt1 (3.0 µl)
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Supplementary Figure 6: Syt1 and Syt7 overexpression in WT neurons increases the fusing fraction 
of DCVs.
a. Fusing fraction as presented in Fig. 3C, but with individual neurons plotted.
b. Fusing fraction as presented in Fig. 3F, but with individual neurons plotted.
c.  Fluorescence intensity of WT neurons overexpressing Syt1 (U = 35.00, p = .0009)
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ABSTRACT
Syt1 and Syt7 are both involved in the secretion of neuropeptides and neuromodu-
lators from dense core vesicles (DCV) in neurons (chapter 2). However, where in 
the DCV secretory pathway both Syts operate remains unclear. In this study, we 
assessed the cellular localization of Syt1 and Syt7 in mouse hippocampal neurons, 
and addressed whether they are present on traveling and fusing DCVs. DCVs, la-
beled by expression of NPY-super ecliptic pHluorin (SEP), highly colocalized with 
endogenous Syt1, and to lesser extent with endogenous Syt7. Expression of Syt7-
SEP, but not Syt1-SEP, combined with bath application of acid/NH4 washes, shows 
that Syt7, and to lesser extent Syt1, localized to the plasma membrane. In contrast, 
Syt1-SEP mainly localized to intracellular acidic compartments. Syt1-SEP traveled 
with DCVs in neurites and was present on fusing DCVs, but Syt7-SEP to a much lesser 
extent. Additionally, Syt7-SEP traveled with lysosomes, Syt1 less so. These results 
suggest that Syt1 and Syt7 localize to largely distinct subcellular compartments. 
Syt1 supports DCV fusion while localized on fusing DCVs, whereas Syt7’s supports 
DCV fusion primarily from another location, possibly the plasma membrane.
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INTRODUCTION
Synaptotagmins are a family of transmembrane proteins that are involved in a 
variety of membrane trafficking events in neurons (for review, see Wolfes and Dean, 
2020). 17 Synaptotagmin paralogs are identified, of which most are expressed in the 
brain (Mittelsteadt et al., 2009). Syt paralogs have different subcellular localizations 
and variable responses to stimulation (Dean et al., 2012). Syt1 is present on synaptic 
vesicles (Brose et al., 1992; Matthew et al., 1981; Takamori et al., 2006), and supports 
synchronous SV fusion (Geppert et al., 1994). Moreover, Syt1 possibly localizes to 
lysosomes (Vukoja et al., 2018), but may not regulate lysosomal fusion (Martinez 
et al., 2000). Syt1 is also present on at least a subpopulation of DCVs in the brain, 
as shown by immunocapture of DCVs (Pons-Vizcarra, 2020), and by subcellular 
fractionation and immunogold labeling (Walch-Solimena et al., 1993). Vesicular tar-
geting of Syt1 depends on an N-glycosylation site at the N-terminal of the protein 
(Han et al., 2004). A Syt1 mutant that lacks the N-glycosylation site is directed to the 
plasma membrane and reduces the readily-releasable pool (RRP) of SVs (Han et al., 
2004). GAP43-Syt1, a mutant that is also located on the plasma membrane, supports 
SV fusion but not endocytosis (Hui et al., 2009; Yao et al., 2012b). This suggests that 
Syt1 localization is a key factor in supporting its diverse biological functions.
Syt7, in contrast to Syt1, localizes mostly to the plasma membrane in neurons 
(Sugita et al., 2001). In synaptic boutons, hemagglutinin-tagged Syt7 locates to a 
distance of ~100 nm from the active zone, but is not present in the active zone itself 
(Wang et al., 2020). Syt7 may also be present on SVs (Sugita et al., 2001; Taoufiq et 
al., 2020), but is not detected by all studies/methods, possibly because Syt7 levels 
on SVs are low and require high sensitivity methods for detection (Takamori et al., 
2006; Taoufiq et al., 2020). Stimulation triggers increased Syt7-pHluorin fluorescence 
in axons exclusively (Dean et al., 2012), suggesting that vesicular Syt7 localization 
of fusogenic vesicles is restricted to axons. In neurons, Syt7 regulates asynchronous 
SV fusion, SV pool replenishment, synaptic facilitation, RRP maintenance and endo-
cytosis (Bacaj et al., 2013, 2015; Jackman et al., 2016; Li et al., 2016; Liu et al., 2014; 
Virmani et al., 2003). Syt7 is also present on lysosomes and regulates lysosomal fu-
sion in fibroblasts (Martinez et al., 2000), and possibly in neurons as well (Padamsey 
et al., 2017). In line with these observations, Syt7KO animals present inflammation 
and fibrosis in skin and skeletal muscle (Chakrabarti et al., 2003), an effect possibly 
related to the function of lysosomal fusion in plasma membrane repair regulated by 
Syt7 (Reddy et al., 2001).
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In neuroendocrine cells, Syt1 and Syt7 support fast and slow secretion respectively 
(Schonn et al., 2008; Voets et al., 2001). The two sensors are targeted to vesicles 
with different diameters, although a subset of secretory granules carry both sensors 
(Bendahmane et al., 2020; Rao et al., 2014; Tawfik et al., 2020; Zhang et al., 2011b). 
In line with their different Ca2+ affinities (Sugita et al., 2002), Syt7 triggers granule 
fusion at lower Ca2+ concentrations than Syt1 and with different fusion kinetics 
(Bendahmane et al., 2020; Rao et al., 2014, 2017).
The lack of additive effect (Chapter 2) together with the functional redundancy of 
Syt1 and Syt7 as mediators of fusion (Chapter 2) suggest that the sensors operate 
in the same pathway, and possibly at the same location. It is currently unknown 
to what extent Syt1 and Syt7 localize to DCVs. Our aim in the current study was to 
address where in the neuron Syt1 and Syt7 are located, and specifically whether 
Syt1 and Syt7 are both present on DCVs. We report that Syt7 is abundant on the 
plasma membrane, whereas Syt1 mainly localizes to acidic intracellular compart-
ments. Syt1, and to a lesser extent Syt7, co-travels with DCVs and co-localizes with 
fusing DCVs. In addition, Syt7, and to a lesser extent Syt1, co-travels with lysosomes. 
Together, these data suggest that Syt1 is present on and necessary for DCV fusion, 
while Syt7 regulates DCV fusion while being largely on the plasma membrane.
RESULTS
Syt1, and to lesser extent Syt7, are present on DCVs
The lack of additive effect in Syt1-KD/Syt7-KO neurons (Chapter 2) suggests that 
Syt1 and Syt7 operate in a single pathway. To address where in the neuron Syt1 and 
Syt7 are located, and specifically whether Syt1 and Syt7 are both present on DCVs, 
we first tested the co-localization in neurites of endogenous Syt1/7 with the DCV 
marker NPY-SEP and synapse marker VGluT1. Colocalization was expressed by the 
Manders M1/M2 coefficient, which reports the co-occurring fraction of color 1 with 
color 2, and ranges from 0 (no overlap) to 1 (complete overlap). Syt1 and VGluT1 
immunostaining largely colocalized (Manders coefficient VGlut1:Syt1 = 0.83 and 
Syt1:VGluT1 = 0.70) (Supplementary Fig. S1), in line with Syt1’s established localiza-
tion on synaptic vesicles (Brose et al., 1992; Matthew et al., 1981; Takamori et al., 
2006). However, at higher laser power, Syt1 puncta were observed extrasynaptically 
(Fig. 1A, Supplementary Fig. S1), and highly colocalized with NPY-SEP (Manders 
NPY:Syt1 = 0.72, Syt1:NPY = 0.62) (Fig. 1A, B). The colocalization between NPY:Syt1 
was significantly higher than NPY:VGluT1 (Fig. 1B, Manders NPY:VGlut1 = 0.40 and 
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0.36 in Syt1KO and Syt7KO neurons, respectively). Together, this suggests that Syt1 
is expressed on DCVs.
NPY-SEP colocalized only partially with Syt7 (Manders coefficient = 0.45) (Fig. 
1C, D), while, conversely, Syt7 colocalized with NPY-SEP and also with the synaptic 
vesicle marker VGluT1 (Manders coefficient = 0.83 and 0.73, respectively). Hence, 
Syt7 localizes to presynaptic terminals and colocalizes with some extrasynaptic 
DCVs, but many DCVs may not express Syt7. Together, this suggests that DCVs 
express Syt1, and to a lesser extent Syt7.
Next, we expressed Syt1 or Syt7 fusion constructs with SEP fused to their N-
terminus, which is expected to be incorporated at the luminal side of DCVs, as 
described for SVs (Perin et al., 1990). In this way, plasma membrane-targeted Syt1/7-
SEP is quenched by application of acidic solution and DCV-targeted Syt1/7-SEP is 
dequenched by NH4. Hence, acid and NH4 washes probe the plasma membrane and 
vesicular fraction of Syt1/7-SEPs, respectively (Fig. 2A). Syt1-SEP was primarily pres-
ent on acidic intracellular compartments with only ±20% on the plasma membrane 
(Fig. 2B, D), in line with previous reports (Liu et al., 2014; Wienisch and Klingauf, 
2006). Syt7-SEP localized predominantly to the plasma membrane, and ~40% was 
localized to acidic intracellular compartments (Fig. 2C, D), also in line with previous 
reports in neurons (Dean et al., 2012; Li et al., 2016; Liu et al., 2014). These results 
suggest that Syt1-SEP and Syt7-SEP have different cellular distributions and that 


















































































Figure 1: Syt1, and to lesser extent Syt7, co-localizes with NPY-mCherry. 
a. Representative image of neuron immunostained for Syt1, NPY-SEP and VGluT1. Scale bar of large 
image =20 µm. Scale bar of zoomed image = 5 µm.
b. Quantification of colocalization between Syt1, NPY-SEP and VGluT1 (X2(5) = 31.74, p < .0001).
c. Representative image of neuron immunostained for Syt7, NPY-SEP and VGluT1. Scale bar of large 
image = 20 µm. Scale bar of zoomed image = 5 µm.
d. Quantification of colocalization between Syt7, NPY-SEP and VGluT1 (X2(5) = 25.25, p < .0001).
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Syt1 is primarily targeted to secretory vesicles, while Syt7 is largely targeted to the 
plasma membrane.
To confirm if Syt1 (and Syt7 to some extent) is indeed targeted to DCVs, we tested 
co-traveling of Syt1/7-mCherry fusion constructs with NPY-SEP, visualized by NH4 
superfusion (Fig. 2E). In contrast to colocalization analysis (Fig 1A-D), co-traveling 
analysis only includes moving puncta/vesicles. To ensure these Syt1/7-mCherry fu-





















































Co-traveling of Syt1 and Syt7 with NPY puncta
























































































Figure 2: Syt1, and to lesser extent Syt7, localizes to intracellular acidic compartments and co-travels 
with DCVs.
a.  Cartoon of Syt-SEP, localized at the plasma membrane or at acidic intracellular compartments, at 
a neutral pH (7.4), and during bath application of acidic pH (pH 5.5) or NH4-containing imaging 
solution.
b, c. Average Syt1-SEP (n = 7 cells) (F) and Syt7-SEP (n = 7 cells) (G) fluorescence response during bath 
application of pH5.5 or 50 mM NH4 Tyrode’s solution.
d. Quantification of plasma membrane/intracellular fraction of Syt1-SEP and Syt7-SEP (X2(4) = 
24.56, p < .0001).
e. Cartoon of co-traveling of NPY-mCherry and Syt-SEP vesicles.
f. mCherry-Syt1 and mCherry-Syt7 partially co-travel with NPY-SEP vesicles. Scale bars = 5 µm.
g. Quantification of co-traveling of NPY with Syt1-SEP or Syt7-SEP, and vice versa (X2(4) = 19.47, p < 
.0002). *p < .05, **p < .01, ***p < .001, ****p < .0001, ns p > .05.
Synaptotagmin-1 and to lesser extent Synaptotagmin-7 co-travel and co-fuse with dense-core vesicles 63
3
sion constructs are functional in DCV fusion, we first confirmed that the mCherry-Syt 
constructs fully rescued DCV fusion in Syt1-KO and Syt7-KO neurons, respectively 
(Supplementary Fig. S2). Next, we tested the co-traveling of these rescue constructs 
with DCV-marker NPY-SEP (Fig. 2F, G). The DCV marker traveled together with Syt1-
mCherry in 64 ± 3% of cases and to a lesser extent with Syt7 (42 ± 4%, Fig. 2F, G). 
These data suggest that Syt1 localizes to DCVs, and Syt7 also, but to a lesser extent.
Syt7 mediates lysosomal fusion in fibroblasts, and recent evidence suggests that 
Syt7 regulates lysosomal fusion in neurons as well (Martinez et al., 2000; Padamsey 
et al., 2017). Therefore, we next assessed whether, in addition to DCVs, Syt1 and 
Syt7 also co-travel with the lysosomal marker LAMP1. For this purpose, LAMP1-EGFP 
was expressed together with mCherry-Syt. LAMP1-EGFP puncta were abundant and 
highly mobile (Fig. 3A). Indeed, Syt7, and to a lesser extent Syt1, co-traveled with 
LAMP1 (Fig. 3B), suggesting a role of Syts in neuronal lysosomal fusion.
The high localization of LAMP1 and Syts, and of NPY and Syts, suggests that 
NPY and LAMP1-EGFP are (partially) expressed on the same organelles. To test 
this hypothesis, we expressed NPY-mCherry with LAMP1-EGFP. NPY-mCherry is a 
red DCV-fusion reporter that detects DCV cargo release (Gandasi et al., 2015) (in 
contrast to NPY-SEP, which detects fusion pore opening). Traveling LAMP1-EGFP 
and NPY-mCherry puncta were abundant and mobile. NPY-mCherry vesicles often 
co-traveled with LAMP1-EGFP (Fig. 4A). We next addressed whether fusing NPY-
mCherry vesicles are LAMP1+ or LAMP1-. None of the fusing NPY-mCherry vesicles 































































Figure 3: Syt7, and to lesser extent Syt1, co-travels with LAMP1-EGFP.
a. Representative examples of traveling EGFP-LAMP1+ puncta and mCherry-Syt1+ (left panel) or 
mCherry-Syt7+ (right panel). 
b. Quantification of colocalization between LAMP1 and Syt1 (green), and LAMP1 and Syt7 (white/
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Figure 4: NPY-mCherry vesicles co-travel with LAMP1, but only LAMP- NPY+ vesicles fuse.
a. Representative kymograph of NPY-mCherry with LAMP1-EGFP.
b. Representative example of fusing LAMP-EGFP-/NPY-mCherry+ vesicle.
c. Quantification of LAMP1-EGFP presence at NPY-mCherry fusion events. Number before the dash 
represents the number of neurons, and after the dash presents the number of fusion events.
(ncells = 6, nves = 320) co-localized with LAMP1 (Fig 4B, C). This suggests that some 
NPY-mCherry vesicles are LAMP1+, but that these vesicles are not fusogenic.
To test whether Syt1 and Syt7 are present on fusing DCVs, Syt1-SEP or Syt7-SEP 
were co-expressed with NPY-mCherry in Syt1-KO or Syt7-KO neurons respectively 
(Fig. 5A), together with Synapsin-ECFP as synapse marker. DCV fusion events are 
defined as the (sudden) disappearance of NPY-mCherry puncta, and corresponding 
Syt1/7-SEP dequenching in the same location was quantified.
Syt1 is an abundant component of SVs (Brose et al., 1992; Matthew et al., 1981; 
Takamori et al., 2006). Therefore, Syt1-SEP was co-expressed with Synapsin-ECFP to 
discriminate between synaptic and extrasynaptic Syt1-SEP events. Syt1-SEP fluo-
rescence at Synapsin-ECFP labeled synapses showed a strong and gradual increase 
upon stimulation, most likely due to Syt1-SEP expression on fusing SVs (Supple-
mentary Fig. S3), which was not the case at extrasynaptic sites (Supplementary Fig. 
S3). Therefore, only extrasynaptic NPY-mCherry fusion events were analyzed for 
co-occurrence of Syt1-SEP dequenching. Syt1-SEP dequenching directly preceded 
NPY-mCherry loss in 67% of the events (Fig. 5B-C), suggesting that the majority of 
fusing DCVs express Syt1-SEP.
We next tested whether Syt7 is present on fusing DCVs. In 35 ± 0.05% of the DCV 
fusion events, a Syt7-SEP dequenching preceded NPY-mCherry loss (Fig. 5D, E). These 
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Figure 5: Fusing NPY-mCherry vesicles co-localize with Syt1-SEP and to lesser extent with Syt7-SEP 
events.
a. Schematic representation of NPY-mCherry events co-fusing with Syt-SEP.
b. Representative images of fusing NPY-mCherry, with and without increase of Syt1-SEP.
c. Percentage of co-localization of fusing NPY-mCherry events (red lines of typical example traces) 
with sudden appearance of Syt1-SEP (green lines of typical example traces). n represents the num-
ber of cells and the number of extrasynaptic NPY fusion events.
d. Representative images of fusing NPY-mCherry with and without increase of Syt7-SEP.
e. Percentage of co-localization of fusing NPY-mCherry events (red lines of typical example traces) 
with sudden appearance of Syt7-SEP (green lines of typical example traces). n represents the num-
ber of cells and the number of NPY fusion events.
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events occurred at Synapsin-ECFP labeled synapses and outside synapses (Fig. S3). 
Hence, the majority of fusing DCVs does not express Syt7-SEP. Together these data 
suggest that Syt1 is present on traveling and fusing DCVs while Syt7 regulates DCV 
fusion primarily from another location, probably the plasma membrane.
DISCUSSION
In neurons, Syt1 is present on SVs and Syt7 highly localizes to the plasma membrane 
(Brose et al., 1992; Matthew et al., 1981; Sugita et al., 2001; Takamori et al., 2006; 
Taoufiq et al., 2020). Both sensors localize to secretory granules in neuroendocrine 
cells, but largely to different populations (Rao et al., 2014; Tawfik et al., 2020). How-
ever, whether Syt1 and Syt7 localize to neuronal DCVs remains unknown. In this 
study, we show that endogenous Syt1, and to a lesser extent Syt7, colocalized with 
the DCV reporter NPY-SEP (Fig. 1A-D). Syt1-SEP mainly localized to acidic intracellu-
lar compartments, whereas Syt7-SEP localized to the plasma membrane (Fig. 2A-D). 
In line with these observations, NPY-SEP co-traveled with mCherry-Syt1 through 
neurites, but much less so for mCherry-Syt7. Moreover, Syt1 was present on fusing 
DCVs, whereas Syt7 did so to a lesser extent. Syt7, on the other hand, co-traveled 
to a high extent with lysosomal marker LAMP1. Together these results suggest 
that Syt1 is present on fusing DCVs whereas Syt7 regulates DCV fusion while being 
located elsewhere, possibly the plasma membrane.
Our experiments with Syt1/7-mCherry and Syt1/7-SEP show that the two sensors 
are targeted to different cellular locations, Syt1 to DCVs (and SVs) and Syt7 mostly 
to the plasma membrane (Fig. 2, 5). Despite these different cellular locations, over-
expression of these sensors fully compensates for each other’s loss in DCV fusion 
(Chapter 2), producing a normal number of DCV fusion events in neurons (over-)
expressing only one of the two sensors. This indicates that the subcellular location 
of Ca2+-sensors for DCV fusion, and also their Ca2+-sensitivity, is rather different 
between Syt1 and Syt7 (Li et al., 1995; Sugita et al., 2002), and does not have a major 
influence on their capacity to support DCV fusion.
Syt1 mainly localized to intracellular acidic compartments (Fig. 2B, D), as expected 
due to its known targeting to SVs (Brose et al., 1992; Matthew et al., 1981; Taka-
mori et al., 2006). As many as 200-1000 SVs are present per hippocampal bouton 
(Harris and Sultan, 1995; Schikorski and Stevens, 1997), each carrying an estimate 
of 7 - 15 Synaptotagmin molecules per vesicle (Mutch et al., 2011; Takamori et al., 
2006). As a result, immunostaining for Syt1 brightly stains synapses and is therefore 
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generally used as a synaptic marker protein. However, other weaker signals may 
be missed when exclusively focusing on synaptic signals. In this study, we used a 
higher laser power that saturates synaptic areas, to visualize weaker, extrasynaptic 
Syt1 signals. This visualized extrasynaptic Syt1 puncta that frequently colocalized 
with NPY (Fig.1A, B, Supplementary Fig. S1). NPY colocalized for ~72% with Syt1 (Fig 
1B). Moreover, the majority of traveling DCVs co-traveled (64%) and co-fused (67%) 
with Syt1 (Fig 2G, 5C). This is in line with previous reports that detect Syt1 in DCV 
fractions and on isolated DCVs in neurons (Pons-Vizcarra, 2020; Walch-Solimena et 
al., 1993) and in neuroendocrine granules (Matthew et al., 1981). Together, this sug-
gests that DCVs express Syt1 and that Syt1 regulates DCV fusion from this location.
In contrast, Syt7 prominently localized to the plasma membrane, in line with pre-
vious observations (Dean et al., 2012; Liu et al., 2014; Sugita et al., 2001). However, 
a significant portion (40%) localized to acidic intracellular compartments. Syt7 was 
previously not detected on SVs (Sugita et al., 2001; Takamori et al., 2006), but is 
detected when using more sensitive detection methods (Taoufiq et al., 2020), sug-
gesting that low levels of Syt7 may be present on SVs. In this study, we show that 
NPY co-travels (42%) and co-fuses (35%) with Syt7, albeit to a significantly lower 
extent than with Syt1. The lower co-fusion percentages suggest that fusing DCVs do 
not require Syt7 on the vesicle membrane for fusion.
Possibly, overexpression results in localization artefacts (e.g. missorting to the 
plasma membrane or ‘overflowing’ to other locations) unless lentiviruses express 
Syts at endogenous levels in the null-mutants. Using our lentiviral vectors, expres-
sion levels increased 50% and 100% in WT neuron overexpressing Syt1 and Syt7 
respectively (Chapter 2, Fig. S6C, D), and expressed Syt1 to/beyond WT levels in 
Syt1KO neurons (Chapter 2, Fig. S5A-C). Nevertheless, overexpression of Syt1 and 
Syt7 rescued DCV fusion in KO neurons (Chapter 2), suggesting that targeting was 
sufficient to support normal functioning of both Syts. Immunocytochemistry of 
endogenous Syt1 with and without permeabilization shows that ~10% of Syt1 local-
izes to the plasma membrane, and overexpression of Syt1-pHluorin showed ~20% 
surface localization (Wienisch and Klingauf, 2006), similar to our plasma membrane 
fraction of Syt1-pHluorin (Fig. 2B, D). This may indicate that expression of Syt1-SEP 
results in a slight accumulation on the plasma membrane. Similarly, expression of 
Syt1-SEP or Syt7-SEP may result in higher colocalization with DCVs. However, the 
different subcellular targeting of Syt1-SEP and Syt7-SEP was supported by im-
munostaining of endogenous Syt1 and Syt7 with NPY-pHluorin (Fig. 1). Genome 
editing, e.g. expression via CRISPR-Cas9, would allow for expression levels close to 
endogenous levels and would reduce the risk of overexpression artefacts.
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Additionally, Syt7 co-traveled to a high extent with LAMP1 (Fig. 3). Colocalization 
between Syt7 and lysosomal markers has also been observed for neuroendocrine 
secretory granules and lysosomes in fibroblasts (Fukuda et al., 2004; Martinez et al., 
2000), which is in line with Syt7 promoting lysosomal fusion in fibroblasts (Martinez 
et al., 2000) and possibly neurons as well (Padamsey et al., 2017). However, part 
of the lysosomal localization of mCherry-Syts may be a result of the resistance of 
mCherry/GFP-like fluorophores against lysosomal degradation (Katayama et al., 
2008). Nevertheless, mCherry-Syt7 localized with LAMP1-EGFP to a significantly 
higher extent than mCherry-Syt1 suggesting that Syt7-mCherry is targeted to 
LAMP1+ organelles, rather than mCherry alone. LAMP1 is generally considered as 
a lysosomal marker. However, the population of LAMP+ vesicles is heterogeneous. 
Electron microscopy shows that LAMP1 is also detected on autophagic and endoly-
sosomal organelles lacking Cathepsin D/B, the enzymes of degradative lysosomes 
(Cheng et al., 2018). The acidic nature of some of these organelles may explain why 
~40% of Syt7-pHluorin localize to acidic intracellular compartments, as shown by 
acid washes (Fig. 2C, D). Taken together, the data presented in this chapter suggest 
that Syt7 localizes to the plasma membrane and to intracellular acidic compart-
ments, of which some are LAMP1+ and NPY+ vesicles.
In addition to Syt7, Syt1 colocalized considerably with LAMP1, although to a 
lesser extent than Syt7 (Fig 3). Syt1 co-traveling with lysosomal markers has been 
reported before (Vukoja et al., 2018). The Syt1+/NPY+ and Syt1+/LAMP1+ vesicles 
may be (partially) different populations. However, endogenous NPY is sometimes 
targeted to LAMP1+ vesicles, likely for degradation (Nahorski et al., 2018). Likewise, 
we report partial colocalization between NPY and LAMP1 (Fig. 4), showing that the 
population of NPY+ vesicles is heterogeneous. However, only LAMP1-/NPY-mCherry 
vesicles fused (Fig. 4), suggesting that fusing NPY+ vesicles are DCVs and not lyso-
somes.
Together, the findings in this chapter suggest that Syt1 is present on traveling and 
fusing DCVs. Syt7, in contrast, localizes to DCVs to a lesser extent and may regulate 
fusion from another location, possibly the plasma membrane.
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Supplementary Figure 1: Colocalization of endogenous Syt1 and endogenous VGluT1.
a. Representative image of neuron immunostained for Syt1, NPY-SEP and VGluT1 with Syt1 exposed 
at high (also presented in Fig. 4) and low laser power. Scale bar of the large image = 20 µm and of 
the zoomed image = 5 µm.
b. Quantification of colocalization between Syt1 and VGluT1 at low laser power (U = 11.0, p = .02).
























































































































Supplementary Figure 2. mCherry-Syt1 and mCherry-Syt7 rescue DCV fusion.
a. Median number of neuropeptide vesicle fusion events in WT, and Syt1-KO neurons with and with-
out mCherry-Syt1-OE in a cumulative plot.
b. Total number of DCVs per neuron is not significantly different between WT, Syt1-KO and Syt1-
KO+mCherry-Syt1-OE (X2(3) = 3.02, p < .22).
c. Fusing fraction is rescued by overexpressing mCherry-Syt1 in Syt1-KO neurons. (X2(3) = 30.21, p < 
.0001).
d. Same as A, but with Syt7-KO neurons expressing mCherry-Syt7.
e. Total number of DCVs per neuron is not significantly different between WT, Syt7-KO and Syt7-
KO+mCherry-Syt7-OE (X2(3) = 1.08, p = .58).
f. Fusing fraction of WT, Syt7-KO and Syt7-KO neurons expression mCherry-Syt7 (X2(3) = 21.726, p < 
.0001). Box plots are plotted with 25% (Q1) and 75% (Q3) interquartile range and Tukey whiskers. 
Number before and after dash represents number of independent experiments and number of 
neurons, respectively. **p < .01, ****p < .0001, ns = p>.05
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Colocalization of fusing NPY-mCherry 





























































Supplementary Figure  3. Synaptic and extrasynaptic portions of fusing DCVs with Syt7-SEP and 
mean fluorescence intensity of synaptic and extrasynaptic SEP-Syt1 response.
a. Synaptic and extrasynaptic distributions of fusing DCVs with and without a sudden increase of 
Syt7-SEP of data presented in Fig. 5E. Number before and after dash represents number of neurons 
and number of fusing NPY-mcherry, respectively.
b. Mean Syt1-SEP fluorescence of ROIs placed in synaptic and extrasynaptic region with or without 
DCV fusion events. Syt1-SEP in synaptic ROIs show a strong increase in fluorescence upon stimula-
tion (blue line). Extrasynaptic ROIs without DCV fusing events (red line) have little Syt1-SEP fluo-
rescence increase, whereas ROIs with fusion events increase in Syt1-SEP fluorescence (orange line). 
Number before and after dash represents number of neurons and number of ROIs, respectively.
c. Latency between the appearance of the Syt1-SEP signal and NPY-mCherry fusion (of co-fusion 
events presented in Fig. 5, n = 39 events from 8 cells, median = 5.5 s).
d. Latency between the appearance of the Syt7-SEP signal and NPY-mCherry fusion (of co-fusion 
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ABSTRACT
Calcium sensors are essential for secretory vesicle exocytosis, yet little is known 
regarding how calcium sensors regulate fusion pore kinetics. Here, we show that 
the duration of single dense-core vesicle (DCV) fusion events was reduced in Syn-
aptotagmin-1 (Syt1)-deficient neurons, but not in Synaptotagmin-7 (Syt7)-deficient 
neurons. Syt7 overexpression did not rescue event duration in Syt1-deficient neu-
rons, suggesting that Syt7 does not support fusion pore duration/stability. Addi-
tionally, Syt1 overexpression in WT neurons, but not Syt7 overexpression, increased 
the fusion event duration, suggesting Syt1 is sufficient to prolong fusion pores. 
Finally, GAP43-Syt1 did not restore fusion event duration in Syt1 deficient neurons, 
possibly because vesicular localization of Syt1 is required to support normal fusion 
pore duration. We conclude that Syt1, but not Syt7, regulates fusion pore duration. 
Syt1 triggers fusion and additionally promotes a prolonged open state of the fusion 
pore.
Keywords: Fusion pore duration, dense-core vesicles, Synaptotagmin-1, Synapto-
tagmin-7, hippocampal neurons
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INTRODUCTION
Neuronal communication primarily relies on the Ca2+-dependent secretion of 
chemical signals from two secretory organelles: synaptic vesicles (SVs), which re-
lease neurotransmitters, and dense-core vesicles (DCVs) secreting neuropeptides. 
Ca2+ regulates vesicle fusion pore opening as well as the fusion pore size and expan-
sion rate (Fernández-Chacón and Alvarez de Toledo, 1995; Hartmann and Lindau, 
1995; Wang et al., 2006). After DCV pore opening, the fusion pores may fully expand, 
merge with the plasma membrane and exocytose the neuropeptide cargo into the 
extracellular space (Albillos et al., 1997; Alés et al., 1999; van Kempen et al., 2011; Wit 
et al., 2009). Alternatively, fusion pore opening may be restricted, leading to only 
partial cargo release, and subsequently close and acidify, leaving the DCV intact 
(Alés et al., 1999; van Kempen et al., 2011; MacDonald et al., 2006). The latter mode 
is referred to as ‘kiss-and-run’. Therefore, dilation or re-closure of fusion pores may 
regulate the extent of DCV cargo release.
The exocytotic fusion pore consists of a mix of membrane phospholipids and 
the transmembrane domains of SNAREs and Synaptotagmins (Bao et al., 2018a). In 
order to drive fusion, the C2 domains of the main Ca2+-sensor Synaptotagmin-1 (see 
chapter 2) insert into acidic phospholipid membranes (for review, see McMahon et 
al., 2010). Via its interaction with SNAREs, Ca2+ and PIP2, an acidic phospholipid in 
the plasma membrane, Syt1 facilitates fusion pore stability and dilation (Bai et al., 
2004b; Das et al., 2020; Holz et al., 2000; Micheva et al., 2001; Wu et al., 2019). In silico 
studies suggest that Syt1 acts as a lever that increases pore size by inserting into the 
plasma membrane after binding Ca2+ (Wu et al., 2019). Indeed, in neuroendocrine 
PC12 cells, a Syt1 mutant with increased membrane interaction, facilitates fusion 
pore expansion and cargo release (Lynch et al., 2008). In line with these findings, 
a Syt1 mutant incapable of binding Ca2+ shortens the event durations of the re-
maining fusion events (Lynch et al., 2008). Summarized, Syt1 requires its membrane 
interaction and Ca2+, not only to open fusion pores, but also to support fusion pore 
stability, dilation and subsequent cargo release.
In neuroendocrine cells, fusion pores of secretory granules can be accurately stud-
ied by amperometry, which reports the opening and dilation of fusion pores with a 
pre-spike foot (PSF). The PSF is studied to gain insight in the initial fusion pore, which 
may last up to several seconds prior to full expansion of the pore, and is caused by 
release of small amounts of norepinephrine (NE) (Albillos et al., 1997; Chow, 1992; 
Jankowski et al., 1993). Changes in PSF kinetics or duration probably reflect changes 
in fusion pore expansion. Consistent with this concept, expression of a Syt1 mutant 
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with an increased linker length between the C2 domains in PC12 cells shortens the 
PSF duration, which suggests that the fusion pore stability was reduced (Bai et al., 
2004a). Overexpression of Syt1 increased PSF duration, suggesting fusion pore sta-
bility increased (Wang et al., 2001). Together, Syt1 promotes duration pore stability/
duration and facilitates fusion pore expansion in neuroendocrine secretion.
In PC12 cells, Syt1 mediates fusion events with a shorter event duration, whereas 
Syt7 fusion pores remain open for a longer amount of time (Bendahmane et al., 
2018). Replacement of Syt1 C2 domains for Syt7 C2 domains slows fusion event 
durations, suggesting that Syt1 and Syt7 differentially regulate fusion event dura-
tion in PC12 cells (Bendahmane et al., 2018). In Syt7KO chromaffin cells, DCV cargo is 
released faster (Bendahmane et al., 2020) and planar lipid fusion Syt7 slows the rate 
of cargo release (Bendahmane et al., 2020).
To test whether Syt1 and Syt7 differentially regulate pore kinetics of neuronal DCVs, 
we analyzed the duration of DCV fusion events in Syt1-KO and Syt7-KO neurons, with 
and without Syt1 and Syt7 (cross-)expression. We show that Syt1 deficiency, but not 
Syt7 deficiency, strongly reduced the duration of DCV fusion events. Moreover, the 
number of fusion events resulting in full cargo release was reduced in Syt1KO neu-
rons. Syt1 overexpression in WT neurons, but not Syt7 overexpression, increased the 
fusion event duration suggesting Syt1 is rate-limiting and sufficient to prolong fusion 
pore opening. Finally, GAP43-Syt1, a Syt1 mutant that lacks its TM domain and instead 
contains a palmitoylation site, did not restore fusion event duration in Syt1 deficient 
neurons. We conclude that Syt1, but not Syt7, prolongs fusion pore duration of DCVs.
RESULTS
Syt1, but not Syt7, prolongs fusion pore duration
Syt1 and Syt7 regulate fusion pore dilation and stability in PC12 and chromaffin 
cells (Bai et al., 2004a; Segovia et al., 2010; Wang et al., 2001, 2006; Zhang et al., 
2010). To test this in neurons, the duration of single fusion events was assessed in 
all genotypes. The duration was defined as the time between the onset of NPY-SEP 
dequenching, indicating fusion pore opening, and return to baseline levels, indicat-
ing either (a) fusion pore closure followed by vesicle re-acidification (‘kiss-and-run’), 
or (b) complete DCV cargo release (‘full fusion’) followed by cargo diffusion in 
extracellular space (Wit et al., 2009). The duration of DCV fusion events was highly 
variable (Fig. 1A-H, also see Chapter 2, Fig. S1A), probably due to (a1) variable fission 
efficiency for kiss-and-run events; (a2) variable expression of proton pumps per 
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DCV, (b1) variable cargo condensation limiting diffusion out of DCVs, and (b2) cargo 
binding to the extracellular matrix limiting diffusion after full vesicle collapse (Wit et 
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We observed that the duration of NPY-SEP fusion events was indeed highly variable, 
ranging from transient events taking ≤ 0.5 s (the minimum duration within the temporal 
resolution of our assay), to events persisting throughout the full time of the recording 
(> 50 s). In WT neurons, single fusion events lasted for 10 to 15 seconds (median event 
duration; Fig. 1D, F, H). In Syt1-KO, relatively more transient events (< 5 s) and less persis-
tent events were observed, reducing the median duration to 5.5 seconds (Fig. 1C-F). As 
expected, the event duration was rescued by overexpression of Syt1 in Syt1-KO neurons 
(Syt-1 OE; 16.5 s, Fig. 1C-D). However, overexpression of Syt1 in Syt7-KO neurons did not 
increase the event duration. In contrast, Syt7-OE did not rescue the shorter event dura-
tion in Syt1-KO neurons (5.4 s, Fig. 1E-F). Moreover, in Syt7-KO, and Syt7-KO + Syt7-OE, 
fusion event duration was not affected (Fig. 1G, H). Together, the data suggests that Syt1 
regulates fusion event duration, which is not supported by, but requires, Syt7.
Syt1 deficiency reduces the number of full DCV fusion events
The shortened DCV fusion event duration in the absence of Syt1 may result from an 
increased speed of cargo release after full collapse of a vesicle with the plasma mem-
brane or reflect an unstable fusion pore that rapidly collapses after pore opening. 
To test whether the remaining fusing vesicles in Syt1 deficient neurons release DCV 
cargo, we expressed NPY-mCherry in Syt1-KO neurons. Upon stimulation, NPY-mCherry 
fluorescence rapidly decreases (A), reporting cargo release upon DCV fusion. Wild-type 
(WT) neurons showed ~42 fusion events in response to high frequency stimulation, 
considerably less than the number of NPY-pHluorin events (Chapter 2). In Syt1-KO neu-
rons, the number of full fusion events was reduced by 83% to 7 fusion events per neuron 
(B, D). These data show that Syt1 deficient neurons still release DCV cargo, albeit that 
the number of fusion events is strongly reduced, consistent with the data in chapter 2.
Figure 1: Synaptotagmin-1, but not Syt7, is required for event duration.
a. Representative images of NPY-SEP events.
b. Representative fluorescence traces of NPY-SEP event regions of interest (ROIs).
c. Normalized cumulative median event duration per neuron in WT, Syt1-KO and Syt1-KO neurons 
with Syt1-OE. For lentiviral infection, 2 µl of lentivirus was used.
d. Event duration in Syt1-KO neurons is rescued by Syt1-OE (X2(3) = 13.27, p = .0013).
e. Normalized cumulative median event duration per neuron in WT, Syt1-KO and Syt1-KO neurons 
with Syt7-OE.
f. Event duration in Syt1-KO neurons is not rescued by Syt7-OE (X2(3) = 13.28, p = .0013).
g. Normalized cumulative median event duration per neuron in WT neurons, Syt7-KO and Syt7-KO 
neurons with Syt7-OE.
h. Event duration is unaltered in Syt7-KO neurons with Syt1-OE and Syt7-OE (X2(4) = 1.475, p = .67). 
Median value is presented in or next to the box plot. Number before and after dash represents num-
ber of independent experiments and number of neurons, respectively. All data presented in this fig-
ure corresponds to data presented in Chapter 2, Fig 4. **p < .01, ***p < .001, ns p>.05.
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Syt1 is rate-limiting for fusion pore regulation
To test whether Syt1 is also rate-limiting for fusion pore duration (as for fusion triggering, 
Chapter 2), we assessed if Syt1 overexpression in WT neurons increases fusion event du-
ration. Indeed, Syt1 overexpression (Fig. 3A, B) prolonged event duration as compared 
to WT, whereas Syt7 overexpression did not (Fig. 3C, D). This suggests that endogenous 
levels of Syt1 are rate-limiting for prolonging the duration of DCV fusion events.
The transmembrane domain of Syt1 is required for fusion pore regulation
The transmembrane domain (TM) of Syt1 has been postulated to orientate Syt1 
to interact with lipids and SNARE proteins (Lee et al., 2010; Stein et al., 2007). To 
elucidate whether the TM domain of Syt1 is required for fusion and/or for a nor-
mal fusion pore duration, the TM domain of Syt1 was replaced by a 40-amino acid 
GAP43-sequence containing a palmitoylation site (Fig. 4A). This replacement is 
reported to almost completely abolish vesicular targeting and induce retargeting 
to the plasma membrane (Hui et al., 2009; Yao et al., 2012a). To test whether plasma-
membrane targeted Syt1 supports fusion pore opening and duration, GAP43-Syt1 
was expressed in Syt1-KO neurons (Fig. 4B). Again, Syt1-KO showed a strong 
decrease in DCV fusion and released fraction (Fig. 4C-D), as previously observed 
WT
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Figure 2: The number of NPY-mCherry events is reduced in Syt1-KO neurons.
a. Cartoon and representative example of NPY-mCherry fusion event.
b. Median number of neuropeptide vesicle fusion events per neuron in a cumulative plot in Syt1-KO 
and WT neurons.
c. Normalized median number of neuropeptide vesicle fusion events per neuron in a cumulative plot 
in Syt1-KO and WT neurons.
d. Deficiency of Syt1 reduces the number of fully fusing DCVs per neuron (U = 53.0, p = .0069).
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(Chapter 2). GAP43-Syt1 expression rescued DCV fusion in Syt1-KO neurons (Fig. 4C) 
and released fraction (Fig. 4D) to WT levels. However, GAP43-Syt1 expression failed 
to prolong the event duration in Syt1KO neurons (Fig. 4E, F). In contrast, GAP43-Syt7 
did not rescue DCV fusion in Syt7-KO neurons and did not alter event duration (Fig. 
4G-L). These data indicate that Syt7, unlike Syt1, requires its TM domain to support 
DCV fusion, and that Syt1 requires its TM domain to regulate fusion pore duration 
(either for functional protein formation and/or correct targeting).
WT neurons with Syt1 overexpression
































































Figure 3: Syt1-OE, but not Syt7-OE, increases DCV event duration
a, b. Fusion duration is prolonged in WT neurons with Syt1-OE (U = 218, p < .05).
c, d. Fusion event duration is not affected in WT neurons with Syt7-OE (U = 258, p = .89).
Median value is presented in or next to the box plot. Number before and after dash represents num-
ber of independent experiments and number of neurons, respectively. All data presented in this fig-
ure corresponds to data presented in Chapter 2, Fig 5. *p < .05, ns p>.05.




























































































































































































Figure 4: GAP43-Syt1 rescues DCV fusion, but not event duration. 
a. Cartoon of GAP43-Syt1 fusion protein membrane-anchored by its palmitoylation site.
b. Immunocytochemistry of Syt1-KO neurons expressing GAP43-Syt1. Scale bar = 5 µm.
c. Median number of neuropeptide vesicle fusion events in WT and Syt1-KO neurons with and with-
out GAP43-Syt1 in a cumulative plot. See Fig. 2A,B for Syt1-KO neurons rescued with Syt1.
d. Fusing fraction in Syt1-KO neurons is rescued by GAP43-Syt1 expression (X2(3) = 10.34, p = .006).
e. Normalized cumulative median event duration per neuron in WT, Syt1-KO and Syt1-KO neurons 
with GAP43-Syt1 expression.
f. Event duration in Syt1-KO neurons is not rescued by GAP43-Syt1 expression (X2(3) = 9.27, p = .01).
g. Cartoon of GAP43-Syt7 fusion protein targeted to the membrane by its palmitoylation site.
h. Immunocytochemistry of Syt7-KO neurons expressing GAP43-Syt7. Scale bar = 5 μm.
i. Median number of neuropeptide vesicle fusion events in WT and Syt7-KO neurons with and with-
out GAP43-Syt7 in a cumulative plot. See Fig. 2E,F for Syt7-KO neurons rescued with Syt7.
j. Fusing fraction in Syt7KO neurons is not rescued by GAP43-Syt7 expression (X2(3) = 10.56, p = .005).
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DISCUSSION
DCV fusion equally depends on two Ca2+ sensors that compensate for each other 
upon overexpression (Chapter 2). However, both sensors localized to different cel-
lular locations (Chapter 3), and it remained unclear if Syt1 and Syt7 differentially 
regulated vesicle fusion. In addition to its role in vesicle fusion Syt1 regulates fusion 
pore stability and kinetics of SVs, and secretory granules in neuroendocrine and 
PC12 cells (Bai et al., 2004b; Das et al., 2020; Holz et al., 2000; Lai et al., 2013; Li et al., 
2016; Lynch et al., 2008; Micheva et al., 2001; Wang et al., 2001, 2003, 2006; Wu et al., 
2019; Zhu et al., 2007). To explore whether Syt1 and Syt7 differentially affected fusion 
kinetics, we investigated the role of Syt1 and Syt7 on fusion event duration. In this 
study we show that Syt1 deficiency, but not Syt7 deficiency, strongly reduces DCV 
fusion event duration. Overexpression of Syt7 in Syt1-KO neurons did not restore a 
normal fusion event duration. Together, these observations suggest that Syt1, but 
not Syt7, regulates DCV fusion pore duration. Moreover, Syt1 overexpression in WT 
neurons, but not Syt7 overexpression, increased the fusion event duration indicat-
ing that Syt1 is sufficient to prolong fusion event duration. Finally, GAP43-Syt1 fully 
rescued DCV fusion, but not a normal fusion event duration. Together, these data 
suggest that the pore duration, but not the pore opening, requires the luminal/
transmembrane domain of Syt1.
Syt1 deficiency, but not Syt7 deficiency, shortened the duration of DCV fusion 
events (Fig. 1A-H). This is consistent with previous observations of shortened event 
duration of single SV fusion events in Syt1-KO neurons (Li et al., 2016). A shorter 
event duration may reflect a narrow fusion pore that recloses after opening (kiss-
and-run), or an enhanced pore dilation whereby the cargo is released more rapidly 
(full fusion). Alternatively, Syt1 deficiency may affect cargo aggregation and subse-
quently alter the time it takes for the crystalline core to dissolve. However, the main 
indicator of cargo processing and crystallization, the pH, was not visibly changed in 
neurons as Syt1 deficient vesicles were still quenched (Fig. 1A). Therefore, Syt1 may 
regulate fusion event duration by affecting pore stability/dilation.
k. Normalized cumulative median event duration per neuron in WT, Syt7-KO and Syt7-KO neurons 
with GAP43-Syt7 expression.
l. Median event duration in Syt7-KO neurons is not affected by GAP43-Syt7 expression (X2(3) = 
1.305, p = .52).
Box plots are plotted with 25% (Q1) and 75% (Q3) interquartile range and Tukey whiskers. Number before 
and after dash represents number of independent experiments and number of neurons, respectively.
* p <.05, ** p < .01, ***p < .001, ns p > .05.
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Overexpression of Syt1 in WT neurons, but not of Syt7, increased the duration 
of fusion events (Fig. 3A-D). This indicates that Syt1 is sufficient to prolong fusion 
event duration. Previous observations in in vitro nanodisk fusion assays showed that 
increasing Syt1 copy numbers resulted in prolonged fusion pore duration (Wu et 
al., 2017b). Similar observations have been made for increasing copy numbers of 
v-SNAREs/VAMP2, where higher copy numbers not only increase the pore duration, 
but also increase the fusion pore size 2-fold and facilitate release of larger cargo 
(Bao et al., 2018a). Therefore, regulation of the expression levels of SNAREs and Syt1 
may provide a cellular mechanism to regulate cargo release. Whereas copy num-
bers of VAMP2 vary considerably between SVs, the copy numbers of Syt1 displayed 
less variation (Mutch et al., 2011), suggesting that Syt1 expression levels are more 
tightly controlled. Taken together, neurons may regulate fusion DCV pore duration 
by regulation of Syt1 expression levels. However, overexpressing either Syt1 or Syt7 
in Syt7-KO neurons did not affect DCV event duration (Fig. 1G, H), suggesting that 
Syt1 requires Syt7 to prolong fusion pores.
An increase in NPY-pHluorin fluorescence (dequenching) reports fusion pore 
opening, whereas the subsequent decrease of NPY-pHluorin either reflects full 
cargo release and diffusion into extracellular space, or pore re-closure followed by 
re-acidification (Wit et al., 2009). Therefore, NPY-pHluorin event duration cannot 
be directly linked to cargo release unless when combined with NPY-mCherry; a 
fluorescent reporter that reports cargo release (but not pore opening) (Gandasi et 
al., 2015). Syt1 regulates fusion pore dilation of liposomes and of secretory granules 
in PC12 cells (Bai et al., 2004b; Das et al., 2020; Lai et al., 2013; Lynch et al., 2008; 
Wang et al., 2001, 2003, 2006), and loss of Syt1 increases the rate of kiss-and-run 
events (Zhu et al., 2007). In neurons, full fusion and kiss-and-run events are present 
(Wit et al., 2009), but it is unclear whether the shortened event duration is related to 
changes in cargo release. Only ~40 full fusion events were detected per neuron (Fig. 
2A-D), whereas ~300-400 NPY-pHluorin events are detected per neuron (Chapter 2). 
This suggests that the large majority of fusion events do not release a large fraction 
of all NPY-SEP contained in single DCVs and may therefore be classified as kiss-and-
run events. Syt1 deficiency reduced the number of fusion pore openings (Chapter 
2). We now show that full fusion events, detected by the sudden disappearance 
of NPY-mCherry, are reduced to a similar extent. This suggests that Syt1 deficiency 
does not selectively affect kiss-and run or full fusion. Therefore, Syt1 may affect the 
duration of fusion pore opening rather than the rate of full fusion/kiss-and-run.
By inserting into the plasma membrane while staying bound to the SNAREs, 
Syt1 has been suggested to act as a lever to dilate fusion pores (Wu et al., 2019). In 
86 Chapter 4
line with these observations, a Syt1 mutant with a gain-of-function for membrane 
insertion showed increased fusion pore expansion and cargo release in PC12 cells 
(Lynch et al., 2008). Indeed, Syt1 requires PIP2 to stabilize fusion pores in nanodisk 
planar bilayer membranes (Das et al., 2020). Together, these data suggest that Syt1 
requires its membrane interaction to support fusion pore stability and dilation. 
The orientation of Syt1 in respect to the vesicle, SNARE complex and PM remains 
a topic of discussion. Lipid mixing assays show that Syt1 requires an asymmetric 
distribution of lipids: more negative charges on the trans-surface are required in 
order to efficiently promote fusion (Lee et al., 2010; Stein et al., 2007). Acidic charges 
at the vesicle membrane cause Syt1 to cis-interact with vesicle membrane, which 
causes Syt1 to lose its Ca2+ stimulatory function (Lee et al., 2010; Stein et al., 2007). 
GAP43-Syt1 is almost exclusively targeted to the plasma membrane (Yao et al., 
2012a), which possibly changes the orientation of GAP43-Syt1 towards membrane 
lipids. This may explain why GAP43-Syt1 does not restore a normal event duration in 
Syt1KO neurons (Fig. 4F). DCV fusion is efficiently restored by GAP43-Syt1 in Syt1KO 
neurons (Fig. 4D), suggesting that the orientation does not affect pore opening in 
neurons. Together, these data suggest that Syt1 supports both fusion pore opening 
and pore stability, and that the vesicular localization is required for supporting fu-
sion pore stability.
Syt7 deficiency or overexpression did not affect DCV fusion pore duration in our 
experiments (Fig. 1G, H, 3C, D), but was previously shown to have a role in pore 
regulation in other systems. Syt7 loss in chromaffin cells resulted in neuroendocrine 
granule fusion pores with a longer lifetime (up to 400 ms, instead of 200 ms for 
WT fusion pores) and a lower conductance, suggesting that fusion pore expansion 
was delayed in Syt7KO neurons (Segovia et al., 2010). Therefore, in neuroendocrine 
granule fusion, Syt7 may support fusion pore expansion. In line with these find-
ings, Syt7KO chromaffin cells release less catecholamines (large molecules), but not 
less ATP (small molecules), suggesting that Syt7 promotes fusion pore expansion 
(Zhang et al., 2019). In contrast, in another study, Syt7KO chromaffin cells have faster 
cargo release (Bendahmane et al., 2020) and planar lipid fusion Syt7 slows the rate 
of cargo release (Bendahmane et al., 2020). Similarly, fusion pores of Syt7-bearing 
granules failed to expand or reseal, slowing the release of vesicle cargo (Rao et al., 
2014). These results suggest that Syt7 regulates pore expansion and cargo release 
in chromaffin cells, but whether Syt7 supports or delays fusion pore expansion 
remains unresolved. Possibly, Syt7 requires a vesicular localization for supporting 
fusion pore duration. Syt7 may support fusion pore duration while being localized 
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to secretory granules on chromaffin cells, whereas the majority of fusing DCVs did 
not express Syt7 on their membrane.
The fact that Syt1, but not Syt7, regulates fusion event duration suggests that Syt1 
acts downstream of Syt7 in DCV secretion. Unlike other secretory pathways, espe-
cially in synapses and chromaffin cells, the sequence of events is still poorly defined 
and the molecules characterized only partially. At the fusion step, multiple R-SNAREs 
(Hoogstraaten et al., 2020; Shimojo et al., 2015) may work with SNAP25 (Arora et al., 
2017; Shimojo et al., 2015), but the Qa SNARE (syntaxin paralog) and SM-protein 
(Munc18 paralog) are unknown. The Rab3A/RIM/Munc13 complex is essential (Per-
soon et al., 2019) and may act upstream of the SNAREs. The fact that Syt1 regulates 
DCV fusion event duration suggests that at least one role of Syt1 is downstream of 
the action of all these molecules. It is quite plausible that both Syts have additional 
roles, as demonstrated for the synaptic vesicle and chromaffin granule pathways 
(Chang et al., 2018; Tawfik et al., 2020; de Wit et al., 2009). Better definitions of DCV 
pools and their release probabilities are required to define better working models 
for the DCV pathway and the molecular function(s) of Syt1 and Syt7.
Acknowledgements
We thank Robbert Zalm for cloning and producing viral particles; Frank den Oud-
sten, Lisa Laan and Desiree Schut for producing glia feeders and primary culture 
assistance; Joke Wortel for animal breeding; Jurjen Broeke for technical assistance; 
Jurjen Broeke and Alessandro Moro for Matlab programming; Ingrid Saarloos for 
protein chemistry; Frank den Oudsten and Joost Hoetjes for genotyping assistance; 
and members of the CNCR DCV project team for fruitful discussions. This work is 
supported by an ERC Advanced Grant (322966) of the European Union (to M.V.).
Author contributions
R.v.W, R.F.T. and M.V. designed the experiments. R.v.W. collected and analyzed ex-
perimental data, together with J.P., who collected data for Fig. S1C-F. R.v.W., R.F.T. 







SUMMARY OF THE FINDINGS
The aim of this thesis was to characterize the calcium sensors involved in neuronal 
DCV fusion. We investigated the role of four calcium sensors, Synaptotagmin-1 
(Syt1), Synaptotagmin-7 (Syt7), Doc2a and Doc2b, on DCV fusion in mouse hip-
pocampal neurons. In Chapter 2, we show that DCV fusion is strongly and equally 
reduced in Syt1- or Syt7-deficient neurons, and combined Syt1/Syt7 deficiency did 
not reduce fusion further, suggesting the two sensors operate in the same pathway. 
Moreover, the two sensors are functionally redundant upon overexpression (they 
cross-rescue each other’s fusion defect), showing that both sensors support fusion 
when expression levels are raised above endogenous levels. Overexpression of 
either sensor in WT neurons increased DCV fusion. Both sensors required their Ca2+ 
binding sites to support DCV fusion. These results suggest that both Ca2+ sensors 
are required, rate-limiting and redundant for DCV fusion. In Chapter 3, the cellular 
localization of Syt1 and Syt7 in hippocampal neurons is characterized. Syt1 mainly 
localized to acidic intracellular compartments, whereas Syt7 was largely pres-
ent on the plasma membrane. Immunohistochemistry and live-cell co-traveling 
experiments showed that Syt1, aside from its synaptic localization, also strongly 
co-localized with DCVs, whereas Syt7 did so to lesser extent. Hence, Syt1 and Syt7 
localized to different cellular compartments. In Chapter 4, the DCV fusion kinet-
ics in Syt1- or Syt7-deficient neurons are described. We report that Syt1-, but not 
Syt7-deficiency strongly reduced fusion event duration, suggesting that Syt1 has a 
unique role in fusion pore duration/stability. Moreover, Syt1 overexpression, but not 
Syt7 overexpression, increased the fusion event duration, suggesting that Syt1 is 
rate-limiting for fusion pore duration/stability. Finally, the transmembrane domain 
of Syt1, which is required for vesicular targeting, is required to restore fusion pore 
duration in Syt1-deficient neurons. We conclude that DCV fusion requires two 
calcium sensors, Syt1 and Syt7, and that, despite differences in localization, these 
sensors can compensate for each other upon overexpression, but that only Syt1 
supports fusion event duration.
SYT PARALOGS HAVE SPECIALIZED FUNCTIONS IN OTHER SYSTEMS
Seventeen Synaptotagmin paralogs are described in mammals (Craxton, 2004, 
2007; Kwon et al., 1996), raising the important question: ‘why so many?’ (Südhof, 
2002). Each sensor has a unique combination of Ca2+ binding properties and cellular 
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localization, which allow Synaptotagmins to fulfil a diversity of cellular functions. 
Syt1, Syt2 and Syt9 are low-affinity Ca2+ sensors for synchronous SV fusion (Gep-
pert et al., 1994; Xu et al., 2007). Syt3, Syt5, Syt6 and Syt10 are medium-affinity Ca2+ 
sensors forming dimers by a S-S bond at the N-terminus (for review, see Südhof, 
2002). Little is known about the roles of this group of sensors, although Syt10 is 
involved in fusion of IGF-1 vesicles in the olfactory bulb (Cao et al., 2011), and Syt3 
regulates AMPA receptor endocytosis (Awasthi et al., 2018). Synaptotagmins that do 
not bind Ca2+ (Syt4, 8, 11-17) may negatively regulate DCV fusion (Dean et al., 2009; 
Zhang et al., 2011a, 2009) and are involved in endocytosis and short- and long-term 
plasticity (for review, see Wolfes and Dean, 2020). Finally, Syt7 is a high Ca2+ affinity 
sensor, involved in asynchronous SV fusion, vesicle replenishment, synaptic facilita-
tion, slow secretory granule secretion and priming in chromaffin cells (Schonn et al., 
2008; Südhof, 2002; Tawfik et al., 2020).
In several systems, multiple sensors regulate fusion: SV fusion and chromaffin gran-
ule (CG) fusion are both regulated by Syt1 and Syt7. But in these systems, Syt1 and 
Syt7 have specialized functions: Syt1 for synchronous (SV) / fast (CG) fusion, and Syt7 
regulates asynchronous (SV) / slow (CG) fusion. Additionally, the two sensors appear 
to be targeted to different CG populations in chromaffin cells (Rao et al., 2014, Tawfik 
et al., 2020) and regulate CG exocytosis with different fusion kinetics: Syt1 promotes 
fusion pore dilation and cargo release (Bai et al., 2004b; Das et al., 2020; Holz et al., 
2000; Micheva et al., 2001; Rao et al., 2014; Wu et al., 2019), whereas Syt7 slows fusion 
pore dilation and release cargo, and promotes fusion at lower Ca2+ concentrations 
than Syt1 (Bendahmane et al., 2020; Rao et al., 2014, 2017; Wang et al., 2005; but also 
see Zhang et al., 2011b, Segovia et al., 2010). Therefore, Synaptotagmins generally 
fulfill specialized functions in neurons and chromaffin cells, with Syt1 regulating 
synchronous SV fusion and Syt7 regulating slower functions. In contrast, we report 
that the two sensors are functionally redundant in neuronal DCV fusion, and found 
no obvious fast/slow specialization for either sensor, suggesting that Syt1 and Syt7 
can fully compensate for each other’s functions in DCV fusion (with exception for 
prolonging fusion pores, see Chapter 4). These data show that the mechanism of 
neuromodulator secretion is different from previously studied systems.
In following sections, we argue that Syt1 and Syt7 expression may function as a ‘vol-
ume dial’ for DCV fusion (Section 3). Next, we discuss why two functionally redundant 
sensors are required for DCV fusion (Section 4). Furthermore, we have not detected a 
fast/slow specialization in DCV fusion, in contrast to SV and CG fusion, and we discuss 
this in relation to Ca2+ sources and from an evolutionary perspective (Section 5). Ad-
ditionally, the molecular mechanisms of Syt in DCV fusion are discussed (Section 6), 
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followed by how secretion of different neuropeptide cargo may be regulated (Sec-
tion 7). We argue for a larger role for neuropeptides in disease models (Section 8) and 
provide a model on how two sensors regulate DCV fusion/neuropeptide secretion 
(9). Finally, we provide suggestions for future research (Section 10).
SYTS MAY FUNCTION AS A ‘VOLUME DIAL’ FOR DCV FUSION
Deletion of Syt1 or Syt7 severely reduced DCV fusion, whereas both sensors were 
functionally redundant upon overexpression (Chapter 2). Moreover, overexpres-
sion of Syt1 or Syt7 in wildtype neurons increased expression levels (Chapter 2, Fig. 
S6) and DCV fusion (Chapter 2, Fig. 5). Together, this suggests that DCVs require a 
minimal number of Syts to trigger vesicles fusion, that both Syts are rate-limiting for 
DCV fusion and that Syt expression levels regulate the number of DCV fusion events. 
In contrast, overexpression of Syt7 in Syt1-KO neurons did not increase SV release 
during train stimulation (Bacaj et al., 2013). Moreover, Syt1-OE in WT neurons did not 
affect evoked IPSC amplitude or spontaneous release (mIPSC) frequency (Courtney 
et al., 2019), suggesting that Syt expression levels are not rate-limiting for SV fusion. 
Hence, Syt1 and Syt7 expression levels regulate DCV, but not SV, fusion in hippocam-
pal neurons. Syt expression levels may hereby act as a ‘volume dial’, whereby increas-
ing Syt expression levels provides neurons a powerful tool to increase the number 
of fusing DCVs. As Syt expression levels are developmentally regulated (Sugita et al., 
2001), these mechanisms may affect neuropeptide secretion during development.
SV fusion requires a minimal number of two SNARE complexes (Sinha et al., 2011), 
and fast neuroendocrine fusion requires three SNARE complexes (Hua and Scheller, 
2001; Mohrman et al., 2010), possibly because a larger vesicle radius (and subse-
quently lower membrane tension) relates to a higher energy barrier for fusion (Lee 
and Schick, 2008; Shillcock and Lipowsky, 2005). Only a few SNAREs are required for 
fusion pore opening, but higher SNARE numbers are required to dilate fusion pores 
and increase pore conductance (Bao et al., 2018b; Wu et al., 2017b). Syt1 also sup-
ports fusion pore dilation and cargo release (Bai et al., 2004b; Das et al., 2020; Holz 
et al., 2000; Micheva et al., 2001; Rao et al., 2014; Wu et al., 2019). We report that DCV 
fusion in Syt1-KO neurons is rescued by lower volumes of Syt1-expressing virus than 
fusion pore duration (Chapter 2, Fig. S5). Taken together, this suggests that higher 
Syt1 expression levels increase pore conductance/neuropeptide release. Regulation 
of Syt expression levels may therefore regulate the number of DCV fusion events 
and the amount of neuropeptide release (also see section below).
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WHY ARE TWO REDUNDANT SENSORS REQUIRED FOR DCV FUSION?
Two very different Syt paralogs are functionally redundant
Cross-expression of Syt1 and Syt7 fully rescued DCV fusion in Syt7-KO and Syt1-KO 
neurons, respectively (Chapter 2, Fig. 4), suggesting that the two sensors are func-
tionally redundant in supporting DCV fusion. This redundancy was rather surpris-
ing, as Syt1 differs from Syt7 in several aspects. First, Syt1 localizes to SVs and DCVs 
(Brose et al., 1992; Matthew et al., 1981; Takamori et al., 2006) (Chapter 3), whereas 
Syt7 is mainly present on the PM and not/to a low extent on SVs and DCVs (Sugita 
et al., 2001; Taoufiq et al., 2020)(Chapter 3). Second, Syt7 has a high affinity for Ca2+ 
(Kd ~1.5-2.5 uM in liposome fusion assays), whereas the intrinsic Ca2+ affinity of the 
C2 domains of Syt1 is 10-fold lower (Kd ~10-20 uM) (Sugita et al., 2002). Addition-
ally, Syt7 has slow phospholipid binding and unbinding kinetics, in contrast to Syt1 
(Hui et al., 2005). Moreover, Syt1 and Syt7 require different C2 domains to trigger 
fusion. Syt7 mediates fusion through its first C2 domain, the C2A domain (Bacaj et 
al., 2013). The C2B domain of Syt7 is dispensable for SV fusion (Bacaj et al., 2013). 
In contrast, Syt1 requires its C2B domain, whereas its C2A domain appears to be 
modulatory (Mackler et al., 2002; Nishiki and Augustine, 2004; Robinson et al., 2002; 
Shin et al., 2009). Finally, as discussed in previous paragraphs, functionally, Syt7 
is generally linked to slower processes that occur at residual Ca2+ concentrations, 
such as asynchronous/slow release, synaptic facilitation, SV/neuroendocrine vesicle 
replenishment and neuroendocrine granule priming (Bacaj et al., 2013; Jackman et 
al., 2016; Liu et al., 2014; Schonn et al., 2008; Tawfik et al., 2020; Wen et al., 2010), 
whereas Syt1 regulates synchronous SV release and fast neuroendocrine granule 
fusion (Geppert et al., 1994; Voets et al., 2001). Taken together, Syt1 and Syt7 differ 
in their localization, Ca2+ affinities, binding kinetics, and C2 domain requirements 
and have specialized (fast/slow) functions in SV and neuroendocrine fusion. Despite 
all of these differences, these two Syt paralogs can fully cross-rescue DCV fusion, 
showing that specific Syt1/Syt7 kinetics, Ca2+ affinity or localization are not essential 
for DCV fusion. Instead, the number of C2 domains/Syt molecules (also see previous 
section), rather than the isoform, regulates DCV fusion. It remains an open question 
what properties make Syt1/Syt7 the preferred Ca2+ sensors over Doc2a/b and other 
Syt paralogs. Probably multiple factors contribute, such as the restricted expression 
in the brain (Syt2, 6, 9, 10), the complete absence of Ca2+ binding (Syt4, 8, 11-17), or 
the absence of the TM domain (Doc2a/b). However, despite the redundancy in DCV 
fusion, Syt1 and Syt7 may still have important unique functions, as will be discussed 
in the following sections.
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Two sensors may differentially regulate cargo release
Both Syts trigger fusion of neuroendocrine granules in chromaffin cells (albeit with 
different fast/slow kinetics), showing that both Syts could act as standalone sen-
sors for vesicle fusion (Schonn et al., 2008; Tawfik et al., 2020; Voets et al., 2001). In 
neuronal DCV fusion, Syt1 and Syt7 cross-rescued Syt7-KO and Syt1-KO neurons, re-
spectively, showing that both Syts trigger DCV fusion pore opening as well (Chapter 
2, Fig. 4). This raises the question: why are two different, but redundant sensors re-
quired for fusion? Syt1, but not Syt7, affected DCV fusion event duration (Chapter 4). 
Also, higher expression levels of Syt1 increased DCV event duration, suggesting that 
Syt1 expression levels regulate fusion pore stability (Chapter 4, Fig. 3). As discussed 
in Chapter 4, Syt1 increases fusion pore size and supports the formation of large, 
stable fusion pores in chromaffin and PC12 cells (Das et al., 2020; Lynch et al., 2008; 
Wang et al., 2006; Wu et al., 2019; Zhu et al., 2007). Similar to neuroendocrine secre-
tion, Syt1 may stabilize fusion pores and increase fusion pore dilation to support 
cargo release from fusing DCVs. Syt7 did not affect DCV event duration (Chapter 4), 
in contrast to previous findings in neuroendocrine cells, where Syt7 regulates fusion 
pore dilation and supports release of large, but not small cargo (Bendahmane et al., 
2020; Rao et al., 2014; Segovia et al., 2010; Zhang et al., 2019) (for discussion, see 
Chapter 4). The different roles for Syt1 and Syt7 in DCV pore duration of fusing DCVs 
suggest that Syt1-mediated fusion supports the release of different DCV cargo than 
Syt7-mediated DCV fusion events by modulation of fusion pores. However, there is 
currently no data that support this hypothesis for DCV fusion in neurons.
Two sensors may regulate fusion with different Ca2+ kinetics
Additionally, the two sensors may regulate vesicle fusion at different Ca2+ levels. In 
neuroendocrine secretion, Syt1 and Syt7 trigger fusion with different release kinet-
ics/timing, with Syt7 promoting release at lower stimulation frequency and at lower 
Ca2+ levels than Syt1 (Rao et al., 2014, 2017; Wang et al., 2005). The Ca2+ affinity is an 
intrinsic property of the Syt gene and similar mechanisms may therefore apply to 
DCV fusion, but may have been missed by our robust stimulation paradigm (16 x 50 
AP at 50 Hz). However, milder stimulation/lower Ca2+ levels may activate Syt7 but not 
Syt1 (due to their respective high and low Ca2+ affinity). As both sensors are required 
for fusion in hippocampal neurons (Chapter 2, Fig. 3), activation of one sensor at low 
Ca2+ concentrations will not trigger fusion of many DCVs. However, the cross-rescue 
(Chapter 2, Fig. 4) suggests that high expression levels of one sensor can compen-
sate for the other. Therefore, at high expression levels Syt7 may efficiently trigger 
fusion, and possibly at lower Ca2+ concentrations. This may especially be relevant for 
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specific groups of neurons that express high levels of one Syt, such as certain nuclei 
in the inferior olive (Turecek and Regehr, 2019), or during developmental regulation 
of Syt1/7 expression levels (Sugita et al., 2001).
Other reasons why two sensors are required
Large vesicles may require more Syt molecules (and SNARE complexes) for fusion, 
because large vesicles have less surface tension and therefore a larger barrier for 
fusion (Nir et al., 1982; Ohki, 1984). Using the same sensors for DCV fusion as for 
SV fusion may be energetically favorable, as strict separation of Synaptotagmin 
paralogs between two secretory systems (SV and DCV) requires an (energetically 
demanding) level of sorting. Additionally, Syt1 and Syt7 may have functional spe-
cializations that were not assessed in this study, such as (1) regulating secretion 
from synaptic (or extrasynaptic) locations, as shown for Munc13-1/2 (Bospoort et al., 
2012); and (2) sensing Ca2+ from different sources (also see discussion at section 5). 
Taken together, two sensors support DCV fusion, but possibly with different cargo 
release, Ca2+ kinetics or fusion locations.
SYT1 AND SYT7 MAY HAVE NO FAST/SLOW SPECIALIZATION IN DCV 
FUSION
Fast DCV fusion may not be detected in our imaging assay
In comparison to SV fusion, DCV fusion is a slow process that requires strong 
stimulation (Fig 1). In contrast the electrophysiological measurements of SV and 
neuroendocrine fusion, neuronal DCV fusion is studied with slower imaging ap-
proaches using fluorescently labelled DCV-cargo. Hence, fast and slow phases of 
DCV fusion are discriminated at a different, slower, temporal resolution. We did not 
detect any changes in DCV fusion timing (the delay between the start of stimulation 
to the dequenching of the vesicle). However, we currently do not know on what 
timescale to expect fast (or slow) DCV fusion. For SV and CG fusion, Syt1-mediated 
synchronous/fast fusion occurs within 20 and 60 ms after stimulation, respectively 
(Geppert et al., 1994; Voets et al., 2001) and asynchronous/slow fusion occurs within 
200 ms and 600 ms, and is regulated by Syt7 (Bacaj et al., 2013; Chen et al., 2017; Luo 
and Südhof, 2017; Luo et al., 2015; Schonn et al., 2008; Tawfik et al., 2020; Turecek 
and Regehr, 2018, 2019; Turecek et al., 2017; Wen et al., 2010). Imaging frames are 
recorded at 2 Hz, and even 500 ms may be too slow to discriminate fast or slow 
fusion. Additionally, DCV fusion requires intense repetitive stimulation (16 x 50 AP 
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at 50 Hz), and it is unclear whether DCVs that fuse later in the stimulation paradigm 
could still be considered ‘fast’ fusion events as these events may quickly follow an 
AP. Because of these two issues, our stimulation paradigm/imaging method does 
not allow for discrimination between fast and slow fusion as defined with electro-
physiological measurements. We could define the fraction of fusion events that 
occur after the last action potential (so after the 16 x 50 AP) as asynchronous/slow 
DCV fusion. This component of DCV fusion may be comparable to delayed release 
in SV fusion, which is the component of asynchronous SV fusion that occurs after 
prolonged stimulation, and is also regulated by Syt7 (Luo et al., 2015; Maximov et 
al., 2008). In contrast, in Syt1-KO and Syt7-KO neurons the fraction of DCV fusion 
events occurring after the stimulation was not significantly affected (Chapter 2, Fig. 
S4). These results suggest that Syts do not specifically affect fast or slow DCV fu-
sion in neurons. DCV fusion may be inherently slow, e.g. due to their localization, as 
will be discussed in the following section. However, imaging methods with higher 
temporal resolution are required to draw stronger conclusions on the role of Syt1/
















































































Figure 1: comparison of SV and DCV fusion speed in a cumulative plot (a) and a zoom of the cumu-
lative plot (b). Hundreds to thousands of SVs are estimated to fuse before a very limited number of 
DCVs fuse. Graphs presents estimated SV data and smoothed DCV fusion data presented in Chapter 
2, Fig. 5A.
DCV localization and Ca2+ sources may contribute to slow DCV fusion
Since Syt1 is among the Ca2+ sensors with the lowest Ca2+ sensitivity (Sugita et al., 
2002), Ca2+ must rise to high micromolar level to activate this sensor, in contrast to 
Syt7, which has a high Ca2+ affinity (Sugita et al., 2002). During mild stimulation, 
calcium influx is specifically high in microdomains near Ca2+ channels, and quickly 
buffered outside these regions (reviewed by Schwaller, 2010). The strong stimulation 
paradigm for DCV fusion (16 x 50 AP at 50 Hz) may increase Ca2+ levels far outside 
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the microdomains, and extend to the location of the DCVs, which typically reside 
outside the active zone (Persoon et al., 2018; Verhage et al., 1991), and partially out-
side synapses. Also, DCV fusion is triggered by partially different (slower) sources for 
fusion than SVs: DCV fusion relies on L-type channels (which have slow activation 
kinetics (for review, see Lipscombe et al., 2004)), and to a lesser extent the faster 
P/Q-type and N-type Ca2+ channels (Leenders et al., 1999; Matsuda et al., 2009; Xia et 
al., 2009), whereas SV fusion requires P/Q-type and N-type Ca2+ channels (for review, 
see Catterall, 2000; Olivera et al., 1994). Moreover, Ca2+ release through ryanodine 
receptors (RyR) from intracellular stores supports BDNF release (Balkowiec and Katz, 
2002; Kolarow et al., 2007). Therefore, it may take time before these slow Ca2+ sources 
increase Ca2+ to concentrations that can activate Syt1. Additionally, DCVs localized 
in synapses were generally not pre-docked to the plasma membrane (Persoon et al., 
2018, but also see Bospoort et al., 2012), and may therefore not be located closely 
to Ca2+ channels. Previous studies indicate a considerable delay between the peak 
of (bulk) Ca2+ increase in axons and the onset of DCV fusion (Persoon et al., 2018). 
Hence, additional factors probably contribute to the slow DCV release onset. For 
instance, DCVs are transported through neurites on molecular motor complexes 
(kinesins, dyneins (Hoogenraad and Akhmanova, 2016; Lo et al., 2011)) and may 
need time to dissociate from these motors and translocate to a fusion site (Bharat et 
al., 2017; Stucchi et al., 2018). Taken together, there may not be a ‘fast/synchronous’ 
phase of DCV fusion, as observed for SV and neuroendocrine granule fusion, due to 
the distal localization of DCVs to their fusion sites and Ca2+ sources.
Lack of evolutionary pressure may cause lack of fast/slow secretion
The lack of fast/slow specialization of Syt1 and Syt7 in DCV fusion stands in contrast 
to SV and secretory granule secretion in chromaffin cells, where both sensors have 
clear specialized functions in fast/slow secretion (see section 2). This difference 
between SV and DCV fusion may be explained by evolutionary adaptations, opti-
mizing CG and SV exocytosis for fast and ultrafast kinetics, respectively. In contrast, 
there may not be a further evolutionary advantage for optimizing neuromodulator 
signalling. Syt1 and Syt7 most likely emerged by gene duplication of an ancestral 
Syt. Our data suggest that this duplication happened first, making secretory path-
ways more efficient and stimulus-dependent, and that Syt1 and Syt7 subsequently 
became more specialized to drive different phases of fast or ultrafast vesicle fusion 
in highly specialized secretory pathways, but not in the DCV pathway.
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MOLECULAR MECHANISMS OF SYT IN DCV FUSION
Both sensors are capable to trigger DCV fusion (Chapter 2, Fig. 3 and 4). Additionally, 
Syt1-KO shortened event duration, and overexpression increased DCV event dura-
tion, suggesting that Syt1 regulates fusion pore stability and dilation (Chapter 4). 
Taken together, Syt1 probably regulates fusion pore opening and stability of DCVs 
in neurons. However, the exact molecular mechanism of Syt7 remains a topic of 
considerable debate. In addition to its role in asynchronous/slow vesicle fusion (Gep-
pert et al., 1994; Voets et al., 2001), Syt7 supports synaptic facilitation (Jackman et al., 
2016) and (independent of Ca2+) slows SV endocytosis (Li et al., 2016). Moreover, Syt7 
supports the Syt1-mediated fast phase of neuroendocrine secretion through priming 
of secretory granules (Schonn et al., 2008; Tawfik et al., 2020). This supporting role on 
the RRP is enhanced when chromaffin cells are pre-stimulated by Ca2+ uncaging of 
0.8 µM Ca2+, which increased the size of the fast burst, suggesting that Syt7 regulates 
vesicle priming in neuroendocrine secretion (Tawfik et al., 2020). In neurons, Syt1 
and Syt7 both (redundantly) maintain the RRP of SVs (Bacaj et al., 2015), and Syt7 
enhances SV docking after stimulation (Vevea et al., 2021). Similarly, Syt7 supports SV 
replenishment during prolonged stimulation and may support vesicle recruitment 
(Liu et al., 2014), suggesting that Syt7 recruits or primes vesicles to the RRP. Therefore, 
Syt7 supports SV, neuroendocrine and neuronal DCV fusion in absence of Syt1, but 
may also regulate priming/docking and/or endocytosis of vesicles in the presence 
of Syt1. However, its role in DCV priming is difficult to assess, because in contrast 
to SVs or CGs, there is currently no clear definition of the RRP for neuronal DCVs (no 
protocol/stimulus to define the release-ready DCV pool like hyperosmotic sucrose for 
SVs or uncaging caged Ca2+ for CGs). Therefore, the ‘primed’ state/pool is not yet de-
fined for DCVs. For these reasons, we cannot discriminate between effects on fusion 
competence or the number of fusion-competent DCVs. The low temporal resolution 
of our imaging assay may not be able to discriminate fast vesicle fusion (by fusion of 
primed/release-ready DCVs) from slow DCVs (see section 5). However, there are indi-
cations that DCV priming occurs on a slow timescale, missed by our imaging assay. 
When applying two stimulations 8 x 50 AP at 50 Hz separated by an interval of ~80 s, 
DCV fusion seems to ‘synchronize’ in the second stimulation (having relatively more 
fusion events in the first 50 AP of the second burst), and this acceleration of fusion 
may be affected in Syt7KO neurons (R. Hoogstraaten, unpublished data). The accelera-
tion in the second burst may result from an increased number of release-ready DCVs 
(e.g. through newly docked/primed vesicles), triggered by Syt7 and the residual Ca2+ 
levels after the first stimulation. As the acceleration requires a time interval between 
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the two stimulations, our experimental set-up (16 x 50 AP) is not optimal to address 
the role of Syt7 in DCV priming. Taken together, Syt7 supports DCV fusion pore open-
ing, which is supported by our data, and may additionally fulfil an upstream role, such 
as priming/pool replenishment, which is not detected with the current stimulation 
paradigm. However, if Syt7 fulfills such roles, they are not unique to Syt7, as Syt1 
overexpression fully compensates for the loss of Syt7 in DCV fusion.
REGULATION OF DIFFERENT NEUROPEPTIDE CARGO
Single cell expression analysis of eighteen neuropeptide genes in cortical neurons 
shows that most neurons express more than one neuropeptide gene, frequently 
between two and seven, but also up to ten per neuron (Smith et al., 2019). Given the 
very different functions of neuropeptide molecules (see Chapter 1), neuropeptide 
cargo may be differentially released. It is currently unknown to what extent these 
neuropeptides are targeted to the same DCVs or whether and how they are sorted 
into different DCV populations, and possibly released by different mechanisms. Some 
neuropeptide cargo, such as IGF-1 and ANF, are targeted to different DCVs (Cao et al., 
2013). However, co-storage of neuropeptides into the same vesicle does occur, as 
shown for BDNF, CGRP and substance P (Salio et al., 2007), and BDNF and substance P 
can be differentially released upon stimulation (Lever et al., 2001). In mouse olfactory 
bulb neurons, Syt10 may specifically regulate a pool of DCVs that secrete IGF-1, but 
not ANF vesicles (Cao et al., 2013). Therefore, Syt paralogs may differentially regulate 
DCVs with specific cargo (see section 4). However, the lack of additive effect in hip-
pocampal neurons (Chapter 2, Fig. 3) suggests that Syt1 and Syt7 act in the same 
pathway and argues against DCV pools that are differentially regulated by these sen-
sors. Therefore, other mechanisms may regulate differential secretion of DCV pools/
neuropeptide cargo. One example of regulation may be by localization of vesicles to 
axons vs. dendrites. Differential release between cellular compartments is reported 
for oxytocin, where stimulation with α-MSH triggers release from dendrites, but not 
axons (Sabatier et al., 2003). Similarly, hypertonic saline triggers axonal vasopressin 
release, whereas dendritic vasopressin is released hours later (Ludwig et al., 1994). 
Indeed, different neuropeptide cargo can be differentially distributed over axons and 
dendrites (Fisher et al., 1988; Landry et al., 2003). Therefore, differential localization 
to axons/dendrites may regulate release of different neuropeptide cargo. However, 
given the large variety in neuropeptides per neuron (Smith et al., 2019), multiple 
mechanisms may be involved to specifically regulate neuropeptide cargo.
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ROLE OF NEUROPEPTIDES IN DISEASE PHENOTYPES
Neuropeptides provide many interesting therapeutic targets, and clinical trials are 
ongoing to treat a variety of diseases (see Chapter 1). In the past five years, FDA 
approved two neuropeptide-drugs: Afamelanotide and Bremelanotide, two α-MSH 
analogs to treat skin damage and hypoactive sexual desire, respectively (de la 
Torre and Albericio, 2020). Despite the effort from researchers and pharmaceutical 
companies, the number of neuropeptide-related drugs on the market remains low. 
The majority of trails fail due to lack of efficacy, e.g. due to low accessibility of the 
brain or low in vivo stability, but also because of unforeseen side effects or safety 
issues. That these side effects can have severe consequences is, among other things, 
reflected by the clinical trial for Rimonabant, an endocannabinoid receptor inverse 
agonist to treat obesity, which was discontinued after reports of severe depression 
and suicide of multiple clinical trial patients (Topol et al., 2010).
Despite receiving considerable attention in clinical trials, few studies address 
neuropeptide release mechanisms. Some Syt1 missense mutations result in a 
dominant-negative effect on neurotransmission and lead to a severe, but hetero-
geneous neurodevelopmental disorder (Baker et al., 2018; Bradberry et al., 2020). K+ 
channel antagonists restore neurotransmission in neurons expressing mutant Syt1 
(Bradberry et al., 2020), but the effects of dominant-negative Syt1 mutations (and 
antagonists) on neuropeptide secretion are currently unknown, but may contribute 
to the disease phenotype. In case of Syt7, deficiency is linked to bipolar-like and 
manic-like behaviour in mice and humans, together with reduced anxiety in the 
light phase of the day, a disorganized circadian rhythm, and a distorted energy 
metabolism in mice (Shen et al., 2020; Wang et al., 2020). This is proposed to be 
caused by attenuated NMDAR activity (Shen et al., 2020; Wang et al., 2020). How-
ever, given the role of Syt7 in neuropeptide signalling (Chapter 2), and the influ-
ence of neuropeptides on circadian rhythm (for reviews, see Freeman and Herzog, 
2011; He et al., 2017), energy metabolism (for review, see Nguyen et al., 2011) and 
anxiety (for review, see Kormos and Gaszner, 2013), it is likely that (Syt7 mediated) 
neuropeptide release contributes to bipolar phenotype. In general, knowledge 
on how neuropeptide transport and release is affected, may provide useful assays 
for efficacy testing of novel therapeutic compounds. Moreover, understanding of 
neuropeptide signalling pathways is essential to select for the most promising drug 
targets and to predict and prevent severe safety issues.
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MODEL
Localization: from which location do Syts support DCV fusion?
This thesis addressed the cellular localization of Syts, and reports that Syt1, and to 
lesser extent Syt7, localizes to DCVs (Chapter 3). This suggests that Syt1 regulates 
fusion while located on vesicles, as previously reported for SVs and CGs (Brose et 
al., 1992; Matthew et al., 1981; Takamori et al., 2006). In contrast, Syt7 localized 
mostly to the plasma membrane and may regulate fusion from this location (Fig. 
2). However, GAP43-Syt7 did not support DCV fusion (Chapter 4, Fig. S1). Syt7 may 
require its TM domain, possibly because the cleavage- and palmitoylation site close 
to the TM domain is essential for Syt7 functioning (Vevea et al. (2021). Syt7 may sup-
port DCV fusion from the plasma membrane, although upstream functions cannot 
be excluded (also see section 6). However, these functions have to be in the same 
pathway as Syt1 as they can be by-passed by Syt1 overexpression (Chapter 2, Fig. 4). 
Therefore, we favour a model where both Syts act together at the same step in the 
secretory pathway, the fusion step, each participating from its specific location: Syt1 
at the vesicle and Syt7 at the plasma membrane.
Additionally, Syt7, and to a lesser extent Syt1, co-localized with trafficking LAMP1+ 
vesicles (Chapter 3). NPY-mCherry also colocalized with trafficking LAMP1+ vesicles 
(for discussion, see Chapter 3). Fusing DCVs, however, never colocalized with LAMP1 
(Chapter 3), suggesting that DCVs are fusogenic but lysosomes may not fuse/release 
cargo in response to our stimulation paradigm.
A single action potential does not trigger DCV fusion
When a single action potential arrives, Ca2+ increases up to 100 µM in the microdo-
mains around Ca2+ channels (Chapter 1). This triggers SV fusion mediated by Syt1 (Fig. 
2, panel 2), which has a low Ca2+ affinity (Sugita et al., 2002). A single action potential 
triggers little asynchronous SV fusion despite Syt7s high Ca2+ affinity, probably due 
to the slow Ca2+ binding kinetics of Syt7 (Hui et al., 2005) combined with rapid Ca2+ 
cellular buffering (Chapter 1). The lack of Syt7 activation may partially explain why 
DCVs do not fuse in response one AP, together with differences in localization of 
DCVs and Ca2+ sources required for DCV fusion (see section 5). Also, Syt1’s low Ca2+ 
affinity combined with the localization on DCVs, which are possibly not pre-docked 
and located further away from Ca2+ channels (see section 5), may also explain why 
multiple action potentials are required for DCV fusion. These properties of Syt1 and 
Syt7 probably prevent substantial DCV fusion during mild stimulation.
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Train of action potentials
When neurons are stimulated repeatedly, Ca2+ increases far outside microdomains 
(Fig. 2, panel 3) (for reviews, see Neher and Sakaba, 2008; Regehr, 2012). This triggers 
synchronous SV fusion, dependent on Syt1 (Fernández-Chacón et al., 2001), but also 
asynchronous fusion, regulated by Syt7 (Bacaj et al., 2013). The strong stimulation 
additionally triggers the fusion of DCVs, at synaptic and extrasynaptic locations, 
and requires both Syt1 and Syt7, which trigger fusion pore opening and possibly 
2. Single action potential
- Local Ca2+ increase
- Syt1 triggers synchronous SV fusion
3. Train of action potentials
- Global Ca2+ increase
- Syt1 and Syt7 trigger syn. and asyn SV fusion
- Syt1 and Syt7 trigger DCV fusion
- LAMP+/NPY+ vesicles do not fuse
1. Localization 
- Syt1 on DCVs and SVs
- Syt7 on plasma membrane 












4. Syt1 regulates fusion event duration
Figure 2: Cartoon of an axon with three synaptic boutons: one in rest (upper), one upon arrival of 
a single action potential (middle) and one upon train stimulation (bottom). 1. Syts partially localize 
to different cellular compartments. 2. A single action potential triggers Syt1-mediated synchronous 
SV fusion, but not DCV fusion. 3. Train stimulation increases Ca2+ globally, activates both Syt1 and 
Syt7 and triggers DCV and SV fusion. 4. Syt1, but not Syt7, prolongs DCV fusion event duration. For 
detailed discussion, see text.
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regulate other upstream processes, such as priming (see section 6). Syt expression 
levels probably regulate DCV fusion efficiency (section 3). The amount of Syt1/Syt7 
involved in DCV fusion may influence the Ca2+ requirements for fusion (section 4) 
and regulate the rate of neuropeptide cargo release through regulation of the fu-
sion pore (section 4).
Syt1, but not Syt7, regulates fusion pore duration
As discussed above, both Syts are required for DCV fusion and probably act at the 
fusion site to trigger fusion pore opening (Fig. 2, panel 4A). After pore opening, a 
DCV can either (1) reseal (‘kiss-and-run’ or cavicapture), without cargo release and 
sparing the DCV (Fig. 2, panel 4B-I), or dilate its fusion pore and merge with the 
plasma membrane (Fig. 2, panel 4 BII-C). Syt1 prolongs DCV event duration, and may 
support dilation of fusion pores and cargo release (see section 4). DCV fusion events 
had a variable event duration and Syt1-pHluorin was present on the majority, but 
not on all fusing DCVs (Chapter 4). Therefore, Syt levels may be variable between 
individual DCVs. As Syt1 prolongs fusion pores (Chapter 4), fusion events that lack 
Syt1 may be the portion of fusion events with shorter duration.
Syt7 did not affect DCV fusion event duration, in contrast to previous findings 
for secretory granules in neuroendocrine cells (Segovia et al., 2010). Possibly, the 
localization of Syts affects whether or not a Syt can support fusion pore stabil-
ity. Syt1 requires lipid interactions to dilate fusion pores in neuroendocrine cells 
(Bai et al., 2004b; Das et al., 2020; Holz et al., 2000; Micheva et al., 2001; Wu et al., 
2019). Possibly, the orientation of plasma membrane Syt with respect to the SNARE 
complex/plasma membrane are incompatible with fusion pore stabilization. This 
could explain why GAP43-Syt1, which previously showed to relocate to the plasma 
membrane (Hui et al., 2009; Yao et al., 2012a), does not rescue DCV event duration 
(Chapter 4). By extension, it may also explain why Syt7, which highly localizes to 
the plasma membrane, does not rescue fusion event duration in Syt1-KO neurons 
(Chapter 4, Fig. S1), even though it triggers fusion pore opening. Therefore, the 
localization of Syts, rather than the paralog, may determine fusion pore duration 
and possibly cargo release from fusing DCVs. However, other factors, such as Ca2+ 
affinity or lipid-interaction preferences, may also contribute to the different effects 




Syt7 as a docking/priming protein
As discussed in section 6, the roles of Syt7 are still under considerable debate. Syt7 
supports the placement of CGs and SVs to the plasma membrane, which may reflect 
priming/docking of vesicles (Tawfik et al., 2020; Vevea et al., 2021). This occurs after 
electrical stimulation or is triggered by pre-stimulation with Ca2+ (Tawfik et al., 2020; 
Vevea et al., 2021). As discussed in section 6, DCV fusion synchronizes in the second 
stimulation when application two stimulations of 8 x 50 AP at 50 Hz, separated by 
~80 s. This stimulation paradigm may be used in WT and Syt7KO neurons to test 
whether Syt7 regulates the synchronization of DCV fusion. Additionally, bath ap-
plication of N-ethylmaleimide (NEM), a substance used to inhibit de-priming of 
vesicles (He et al., 2017a), rescues the priming defect in Syt7KO chromaffin cells 
(Tawfik et al., 2020), suggesting that Syt7 promotes priming by inhibiting de-prim-
ing. NEM may be used to assess whether Syt7 inhibits de-priming of DCVs. These 
experiments would provide further insight on the molecular mechanisms of Syt7 in 
DCV fusion.  
Relation between fusion event duration and cargo release
As discussed previously (section 4, and Chapter 4), Syt1 and Syt7 may differentially 
regulate neuropeptide cargo release. Syt1 prolonged DCV event duration (Chapter 
4), but pore size or conductance has not been assessed in this thesis. In chromaffin 
cells, pore kinetics and catecholamine secretion can be assessed with patch-am-
perometry. Secreted NPY is not detected by amperometry (unless when tagged, see 
Whim, 2006), which complicates studying pore kinetics of fusing DCVs in neurons. 
However, fusion pore size can be tested by bath application of labelled dextrans with 
different sizes (Lynch et al., 2008). Additionally, cargo release is reflected by release 
of NPY-mCherry (Gandasi et al., 2015), which can be combined with NPY-pHluorin 
to simultaneously assess DCV pore opening and cargo release. With these methods, 
future experiments can focus on the relation between fusion pore dynamics and 
cargo release of fusing DCVs, and test whether Syt1 and Syt7 indeed differentially 
regulate neuropeptide secretion from fusing DCVs.
Role of Syt localization on fusion pore stability
Syt1 and Syt7 can cross-rescue DCV fusion but not fusion event duration (Chapter 2, 4). 
GAP43-Syt1 rescued DCV fusion but not event duration, suggesting that plasma mem-
brane targeted Syt1 does not support pore stability. It is currently unknown to what 
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extent Syt localization contributes to Syt functioning. As discussed in Chapter 4, the 
vesicular localization of Syt1 and Syt7 may be required to stabilize fusion pores. Vesicular 
localization of Syt1 depends on a N-glycosylation site, which is required and sufficient 
to target Syt1, but also Syt7, to vesicles (Han et al., 2004). A Syt7-mutant with the N-
glycosylation site may be targeted to DCVs (and SVs) instead of the plasma membrane, 
and may allow to Syt7 promote fusion pore stability of DCVs and expand the repertoire 
of functional redundancy between the two Syts. This construct can be used to specify 
what factors contribute to the unique functions of Syt1 and Syt7 in vesicle fusion.
Roles of Syt in other brain regions
Syt7 is abundantly expressed in the brain (Mittelsteadt et al., 2009) and important 
for both neurotransmitter and neuropeptide vesicle fusion. Nevertheless, Syt7-KO 
mice are viable and fertile (Maximov et al., 2008). In contrast, mice deficient for BDNF 
die early postnatally due to breathing deficits, which can be prevented by sufficient 
BDNF levels in the brainstem (Erickson et al., 1996; Fox et al., 2013). This suggests 
that BDNF secretion in brainstem does not require Syt7 or that Syt7 is redundant 
with other sensors, such as Syt2, which is highly expressed in this region (Pang et al., 
2006). Therefore, the role of Syt paralogs in neuropeptide fusion in other brain areas 
remains a topic for future investigation.
Candidates for a third sensor
Approximately 20% of DCV remained in Syt1/Syt7 double-deficient neurons 
(Chapter 2, Fig. 3). As DCV fusion strictly depend on Ca2+ (Balkowiec and Katz, 2002; 
Hartmann et al., 2001; de Wit et al., 2009), there may be a third sensor that regulates 
secretion. Both Syt3 and Syt51 are universally expressed in most brain areas (Mittel-
steadt et al., 2009; Zeisel et al., 2015) and mediate Ca2+ -dependent liposome fusion 
(Bhalla et al., 2008) and bind SNARE proteins (Vrljic et al., 2010). Very few studies 
address potential roles of Syt3 and Syt5. Both sensors do not mediate synchronous 
release or LTP (Wu et al., 2017a; Xu et al., 2007), but Syt3 mediates AMPA-receptor 
internalization and LTD (Awasthi et al., 2018). No functions are reported for Syt5. 
Given the universal expression in brain, the SNARE, Ca2+ and lipid binding capacity, 
Syt3 and Syt5 are good candidates for DCV fusion in neurons.
1 Syt5 refers to the Syt isoform with medium Ca2+ affinity (GenBank acc.# U20108). In literature, 
Syt9, an isoform with high Ca2+ affinity, mediating fast synchronous fusion in some cell types 







Primary hippocampal cultures were prepared from Doc2ab-DKO and DHz lit-
termates, or Syt1-KO, Syt7-KO C57BL/6J mice with WT littermates, of both sexes. 
Doc2a/b-DKO animals were previously described (Groffen et al., 2010). Syt1-KO 
(Geppert et al., 1994) and Syt7-KO animals (Maximov et al., 2008) were a kind gift 
from T. C. Südhof. Syt heterozygous animals were cross-bred to generate wild-type 
(WT) and knock-out (KO) littermate pups for culturing. Animals were genotyped at 
E18 (Syt1) or P0 (Syt7 and Doc2a/b), prior to culturing. All animals were bred and 
housed in line with institutional and Dutch governmental guidelines and all proce-
dures were approved by the ethical committee of the Vrije Universiteit, Amsterdam, 
The Netherlands (DEC-FGA 11-03 and AVD112002017824).
Primary neuronal cultures
Glia microdot islands were prepared on UV-sterilized, etched, agarose coated 
glass coverslips stamped with 0.1 mg ml−1 poly-D-lysine and 0.2 mg ml−1 rat tail 
collagen and 10 mM acetic acid. Hippocampal cultures were prepared from E18 
Syt1-KO or P0 Syt7-KO animals. As DCV fusion is variable between different litters/
culturing sessions, WT littermates were included as controls. For Chapter 2, Fig. 3, 
Syt1 knock-down was used, because of a higher probability for WT littermates in 
double-Hz breedings (Xu et al., 2012). Animals were quickly decapitated and the 
brains transferred to HBSS buffered with 1 mM HEPES for hippocampal dissection. 
Hippocampi were digested with 0.25% trypsin for 20 min at 37°C in HBSS, washed 3 
times with HBSS, triturated in Glutamax-containing DMEM supplemented with 10% 
heat-inactivated FCS, 1% NEAA solution, and 1% Pen/strep to inactivate trypsin, and 
centrifuged for 5 min. The pellet was gently resuspended in pre-warmed enriched 
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Neurobasal supplemented with 2% B-27, 1.8% HEPES, 0.25% Glutamax, and 0.1% 
penicillin–streptomycin, and counted in a Fuchs-Rosenthal chamber. Cells were 
plated at 2K in pre-warmed, enriched Neurobasal-filled 12 wells Cellstar plates. 
For Western Blot analysis, cortices were isolated and counted as described above, 
and plated on 0.01% poly-L-ornithine and 2.5 µg/ml laminin diluted in Dulbecco’s 
phosphate-buffered saline coated 6-wells Cellstar plates (Greiner Bio-One) at 300K/
well.
Constructs and infections
hNPY-SEP and hNPY-mCherry were made by replacement of NPY-Venus (Nagai 
et al., 2002) with superecliptic pHluorin (SEP) or mCherry. NPY-SEP is used for all 
experiments with exception of those presented in Chapter 3, Fig. 3, 4, 5 and Fig. 
S3. NPY-SEP is targeted to DCVs and quenched by the acidic intraluminal pH. Upon 
DCV fusion pore opening, SEP is rapidly visualized by the pH of the extracellular 
solution (pH 7.4). From this point onwards, a DCV may follow one of two scenarios 
(Wit et al., 2009): (a) fusion pore closing without (full) cargo release, followed by 
re-acidification or (b) diffusion of cargo out of the vesicle (‘full fusion’), which rapidly 
diffuses in the extracellular solution. In both cases, the NPY-SEP signal de-quenches 
to baseline levels, which typically takes several seconds. NPY-SEP is an excellent 
reporter for the duration of a DCV fusion event, but does not discriminate between 
the two scenarios. The duration of NPY-SEP events ranges from 500 ms (the shortest 
measurable duration) to the end of the recording (50 s). If cargo diffusion is fast, 
NPY-SEP fluorescence increase might be too transient to detect reliably, due to the 
sampling rate (250 ms exposure time at 2 Hz). In Chapter 3, Fig. 5 and Supplemen-
tary Fig. S3, Syt1-SEP and Syt7-SEP were used to test if Syt1/7 is on fusing vesicles. 
Here, the disappearance of NPY-mCherry reports full DCV cargo release, and Syt-SEP 
report coinciding deacidification of the fusing vesicle.
 Syt1 open reading frame and Syt1-shRNA were a kind gift from T. C. Südhof (Xu 
et al., 2012). Mouse cDNA was prepared from the short (403aa, ENSEMBL Syt7-201) 
splice variant of Syt7 and sequenced. Syt1 and Syt7 were cloned into a lentivirus 
backbone, additionally encoding a nuclear targeted mCherry signal. To generate Ca2+ 
binding mutant Syts (Syt1-DA and Syt7-DA), Ca2+ binding aspartates where substi-
tuted for alanines as described previously (Bacaj et al., 2013). Fluorescent-Syt fusion 
constructs were made by cloning a fluorescent protein (mCherry or SEP) to the N-
terminus of Syt1 and Syt7, preceded by a preprotachykinin signal peptide to ensure 
ER targeting (kind gift from J. B. Sørensen (Weber et al., 2014)). GAP43-Syt1, encoding 




Chapman (Hui et al., 2009; Yao et al., 2012a). GAP43-Syt7 was generated by fusing the 
coding sequence of GAP43 1-41 aa to Syt7 41-403 aa. All constructs were driven by a 
Synapsin promoter, sequence verified and cloned into a pLenti vector and produced 
as described (Naldini et al., 1996). Syt1-KD and Syt-rescue constructs were applied to 
neuronal cultures at DIV2. All other infections were performed at DIV10.
Live-cell imaging
Live-cell imaging (LCI) was performed at DIV15-20 using a custom-built inverted 
imaging microscope (IX81; Olympus) with an MT20 light source (Olympus), the 
appropriate filter sets (Semrock, Rochester, NY), a 40× oil objective (NA 1.3) and 
an EM charge-coupled device camera (C9100-02; Hamamatsu Photonics, Japan). 
Recordings were made using Xcellence RT imaging software (Olympus). Sampling 
occurred at 2 Hz with an exposure time of 250 ms. Master 8 (AMPI, Germany) and a 
stimulus generator (A385RC, World Precision Instruments, Germany) were used to 
drive two parallel platinum field stimulation electrodes, to deliver 16 trains of 50 
action potentials at 50 Hz with 500 ms intervals. No stimulation was used for Syt-
localization and co-traveling experiments (Chapter 3, Fig. 2, 3, 4). Cultures were kept 
at room temperature (RT; 21–24°C), perfused with Tyrode’s solution (2 mM CaCl2, 2.5 
mM KCl, 119 mM NaCl, 2 mM MgCl2, 30 mM glucose and 25 mM HEPES, pH 7.4). A 10 
sec exposure to Tyrode’s-NH4 (50 mM NH4Cl, 2 mM CaCl2, 2.5 mM KCl, 69 mM NaCl, 2 
mM MgCl2, 30 mM glucose and 25 mM HEPES, pH 7.4) was used to dequench SEP at 
the end of each stimulation. For visualization purposes, brightness, and contrast of 
representative examples was adjusted in a linear and equal fashion between groups.
Immunocytochemistry
Neuronal cultures were fixed with pre-warmed (37°C) 3.7% PFA for 20 min, and 
washed with phosphate buffered saline (PBS, pH 7.4). Cells were washed with PBS 
and permeabilized for 5 min with 0.5% Triton X-100 in PBS, and blocked with 5% 
bovine serum albumin and 0.1% Triton X-100 in PBS for 30 min. Primary and second-
ary antibodies were incubated overnight at 4°C and at RT for 1 hour, respectively. 
Primary antibodies were: anti-Syt1 (SySy, 105 001 and 105 008, anti-Syt7 (Neuromab, 
Q9R0N7), anti-VGlut1 (Millipore, AB5905), and anti-GFP (Bio-Connect, GTX20290 and 
AVES, 1020). Secondary antibodies were: Fisher Emergo 10286672, Life Technologies 
A-11010 and A-21450; Fisher Emergo 10739374, Life Technologies A-11008 and 
A-11074; Life Technologies A-11010 and A-21450; Life Technologies A-11040, A-11001, 
A-21450. Coverslips were mounted in Mowiol 4-88 (Sigma, 81381) and imaged within 
2 weeks on a Nikon confocal laser-scanning microscope with a 40x objective (NA 1.3), 
controlled by NIS Elements 4.30 software. Semrock filter sets for green (500-550 nm) 
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and red (580-650 nm or, when combined with far-red, 590-620 nm) and far-red (long 
pass 650 nm) were used, together with a quad band 405/488/561/635 beam splitter. 
No bleed through was observed for SEP/Alexa 488, Alexa 546 and Alexa 647 in each 
other’s channels. Laser settings were kept constant within experimental conditions. 
For visualization purposes, brightness and contrast of representative examples were 
adjusted in a linear and equal fashion between groups.
Imaging analysis
In ImageJ, ROIs of 3x3 pixels (equals 0.6x0.6 µm) were placed manually on SEP-
fusion events, somatic events not included. Movement of de-quenched vesicles out 
of the ROIs in X/Y direction is very rare, but was detected by an expert observer 
during validation of the ROI placements in the image stack (movie) and lead to 
re-positioning or cancellation of the ROI. ROI intensity measures were exported to 
Matlab for semi-automated detection of fusion events and duration. Intensity traces 
were plotted as ΔF/F0, with the average fluorescence of the first 10 frames used 
to determine F0. Events were defined as a sudden increase of 2 SD above F0. Pool 
estimation was performed using SynD software (Schmitz et al., 2011) in Matlab. For 
this, a neurite mask (soma not included) was drawn in SynD to estimate the number 
of puncta/DCVs. Detection parameters were optimized to detect vesicle puncta and 
kept constant during all datasets. For each neuron, the intensity of an individual 
DCV was estimated by taking the fluorescence intensity mode per cell in the first 
two quantiles. Pool size was estimated by correcting the puncta intensities on the 
individual DCV intensity. Manders overlap coefficient (M1/M2) was determined on 
neurites exclusively, including above-threshold fluorescence as determined in Im-
ageJ using the JACoP plugin (Bolte and Cordelières, 2006). The Mander’s coefficient 
can be defined as the fraction of total signal in one channel that overlaps/co-occurs 
with (above threshold) signal of the other channel: 0 representing no overlap, and 1 
indicating complete overlap.
Statistics
Data that violated normality (D’Agostino-Pearson) and homogeneity (Fligner-
Killeen) was tested with two-sided Mann-Whitney U test or Kruskal-Wallis (gener-
ating a U-statistic and X2-statistic, respectively) and Dunn’s multiple comparison 
with Benjamini-Hochberg correction. For cumulative plots, the cumulative median 
number of events were taken for each time point, for each neuron. Box plots were 
plotted with 25% and 75% interquartile range and Tukey whiskers, presenting the 




number of independent experiments and number of neurons, respectively. When 
assumptions of homogeneity and normality were met, data were tested with 
student’s t-test or 1-way ANOVA and Holm-Sidak correction and plotted as mean 
± SEM. N represents the number of litters, n represents the number of individual 
neurons, unless stated otherwise.
Westen Blotting
To confirm efficiency of Syt1-KD, cells were scraped in loading sample buffer 
(2%SDS, 10% glycerol, 0.26 M B-mercaptoethanol, 60 mM Tris pH 6.8) and loaded 
on a 10% SDS-polyacrylamide gel and transferred on a PVDF membrane. Blots were 
blocked using 2% milk, 0.5% BSA in PBS containing 0.1% Tween-20 for 1h at 4°C, 
and incubated overnight at 4°C with monoclonal mouse-anti-Syt1 (BD Biosciences, 
#610434 and #S39520) and polyclonal rabbit-anti-GAPDH (Abcam, #ab9485) in PBS 
containing 0.1% Tween-20. Blots were imaged using AttoPhos (Promega, S1001) 







The human brain contains billions of brain cells (neurons), which process visual and 
auditory information, regulate muscle movement and execute cognitive functions. 
Neurons communicate with each other through the release of signaling molecules. Of 
these molecules, neurotransmitters are best-known. Neurotransmitter release is very 
fast, as the communication between two neurons takes on 1/50th of a second. Aside from 
this fast communication, neurons also release slow signaling molecules: neuropep-
tides. Neuropeptides regulate numerous processes in the brain. They are the ‘cuddling 
hormones’ of the brain, dampen hyperactivity during an epileptic seizure, let neurons 
grow in response to physical activity, and can be released in the blood stream to regulate 
blood pressure, or trigger start the birth of a child. Understandably, neuropeptides are 
very important for health function of the human brain and body. Multiple clinical trials 
investigate whether neuropeptides provide an effective treatment for diabetes, post-
traumatic stress disorder (PTSD), autism, alcohol addiction, migraine, depression, and 
others.
Release of neuropeptides is accurately regulated by neurons. Neuropeptides are 
not free-floating in the brain cell, but are packaged in vesicles, surrounded by a 
lipid membrane. The vesicles contain many neuropeptide molecules, which gives 
the vesicle a dark core under the microscope. Therefore, neuropeptide vesicles 
are called ‘dense-core vesicles’ (DCVs). Neurons release neuropeptides when the 
calcium concentration in the cell is high. This happens when the neuron is activated: 
channels in the cell membrane open, resulting in calcium influx. Calcium triggers 
the fusion of vesicles with the outer membrane of the neuron, the plasma mem-
brane (Fig. 1). Ca2+ triggers fusion via the activation of Ca2+ binding proteins, the 
Ca2+ sensors. Upon Ca2+ binding, Ca2+ sensors can fuse the membrane of dense-core 
vesicles with the plasma membrane of the neuron. Now, neuropeptides can diffuse 
out of the vesicle and fulfill their signaling function.
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Aim and main findings of this thesis
Neurons express many different calcium sensors, which are all slightly different 
from each other. This thesis describes which calcium sensors regulate the fusion 
of dense-core vesicles with the plasma membrane, which allows for the release of 
neuropeptides.
Chapter 1 provides a general introduction on the topic. I describe the functions 
of neuropeptides, the production of DCVs, how neurons regulate intracellular Ca2+ 
and which proteins (specifically Ca2+ sensors) regulate vesicle fusion.
Chapter 2, describes that two calcium sensors, Synaptotagmin-1 (Syt1) and 
Synaptotamin-7 (Syt7), are required for the fusion of dense-core vesicles, whereas 
two other sensors (Doc2a/b) have no effect on DCV fusion. Both Syt1 and Syt7 are 
required for fusion, because DCV fusion is strongly reduced in absence of these 
sensors. Additionally, the absence of two sensors does not have an additive effect, 
suggesting that both sensors operate in the same pathway. Although both sensors 
are required, they are functionally redundant upon overexpression. Moreover, over-
expression of Syt1 and Syt7 increases DCV fusion, suggesting that both sensors are 
rate-limiting for fusion. As expected, a Ca2+ binding mutant that lacks Ca2+ binding 
does not restore DCV fusion in Syt1-KO or Syt7-KO neurons. Finally, Syt1 and Syt7 
do not specifically regulate ‘fast’ or ‘slow’ DCV fusion in neurons, in contrast to other 
systems, such as SV and neuroendocrine granule fusion. Taken together, both sen-









Figure 1: cartoon of a neuron with a zoom-in of two dense-core vesicles: one filled neuropeptides 





Chapter 3 shows that both calcium sensors are located on different locations in 
the neuron. Synaptotagmin-1 was present on both on fusing and trafficking DCVs. 
Synaptotagmin-7 localized to DCVs to lesser extent, but highly localized to the 
plasma membrane. Syt7 additionally localized to lysosomes. Therefore, Syt1 and 
Syt7 are present on different cellular compartments, and probably support DCV 
fusion from different locations.
Chapter 4 describes the kinetics of fusing dense-core vesicles into greater detail 
and reports that Syt1 and Syt7 differentially regulate the duration of DCV fusion 
events. Syt1 supports fusion event duration: in absence of Syt1, fusion event dura-
tion is shortened, whereas Syt1 overexpression prolongs fusion event duration. This 
suggests that Syt1 supports pore stability of fusing DCVs. Syt7, in contrast, did not 
affect fusion event duration.
In Chapter 5, I summarize and discuss the findings, and provide suggestions on 
how Syt1 and Syt7 regulate DCV fusion. This dissertation provides new insights on 
how Ca2+ regulates neuropeptide release, and identifies two sensor sensors, Syt1 
and Syt7, that are required for DCV fusion. Moreover, I show that DCV fusion differs 
from neurotransmitter and neuroendocrine fusion in certain aspects. Hereby, this 
thesis contributes to our understanding of fundamental molecular mechanisms of 






De menselijke hersenen bevatten miljarden hersencellen (neuronen) die senso-
rische informatie verwerken, spieren aansturen en cognitieve functies uitvoeren. 
Neuronen communiceren met elkaar door de afgifte van signaalstofjes. Van deze 
signaalstoffen zijn neurotransmitters de bekendste. Neurotransmitterafgifte werkt 
heel snel, de communicatie tussen twee neuronen duurt slechts 1/50e van een se-
conde. Naast deze snelle communicatie geven neuronen ook langzame signaalstof-
jes af: neuropeptiden. Neuropeptiden regelen tal van processen in de hersenen. 
Ze zijn het ‘knuffelhormoon’ van de hersenen, dempen overactiviteit bij een epilep-
tische aanval, laten neuronen groeien na het sporten, kunnen in de bloedbaan af-
gegeven worden en bloeddruk regelen of de geboorte van een kind in gang zetten. 
Begrijpelijkerwijs zijn neuropeptiden erg belangrijk om gezond te functioneren. Er 
lopen klinische trials die onderzoeken of neuropeptiden ingezet kunnen worden 
voor goede behandelingen bij diabetes, posttraumatisch stresssyndroom (PTSS), 
autisme, alcoholverslaving, migraine, depressie en andere aandoeningen.
De afgifte van neuropeptiden wordt nauwkeurig gereguleerd door neuronen. 
Neuropeptiden zweven niet los door de hersencel, maar zijn verpakt in blaasjes 
(vesicles), omgeven met een vetmembraan. De vesicles bevatten erg veel neuro-
peptidemoleculen, waardoor de vesicles onder de microscoop een donkere kern 
hebben. Daarom heten ze dense-core vesicles (DCVs). Neuronen geven neuropep-
tiden af wanneer er veel calcium in de cel is. Dit gebeurt wanneer het neuron actief 
is: kanaaltjes in het celmembraan schieten open en calcium vloeit de cel binnen. 
Calcium triggert de fusie van vesicles met de buitenkant van de hersencel, het 
plasma membraan (Fig. 1). Calcium doet dit niet op zichzelf, maar door te binden 
aan Ca2+-sensoren. Wanneer Ca2+-sensoren Ca2+ binden, kunnen ze het plasma-
membraan fuseren met het vesicle-membraan. Hierdoor worden de neuropeptiden 
afgegeven en kan het zijn signaalfunctie vervullen.
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Doel en hoofdbevindingen van deze thesis
Er zijn veel verschillende calcium sensoren, die allemaal net een beetje anders zijn. 
Deze thesis beschrijft welke calcium-sensoren er voor zorgen dat DCVs met het 
celmembraan fuseren, waardoor neuropeptiden afgegeven kunnen worden.
Hoofdstuk 1 geeft een algemene introductie van het onderwerp. Ik beschrijf de 
functies van neuropeptiden, de productie van DCVs, hoe neuronen Ca2+ reguleren 
en welke eiwitten (in het bijzonder Ca2+-sensoren) de fusie van vesicles regelen.
In hoofdstuk 2 beschrijf ik dat twee calcium sensoren, Synaptotagmin-1 (Syt1) 
en Synaptotamin-7 (Syt7), nodig zijn voor de fusie van DCVs, maar dat twee andere 
sensoren (Doc2a/b) geen invloed hebben op DCV-fusie. Zowel Syt1 en Syt7 zijn 
nodig voor fusie, want als één van de twee wegvalt, fuseren er bijna geen DCVs 
meer. Bovendien zorgt de afwezigheid van beide sensoren niet voor een sterkere 
reductie in fusie dan wanneer één van de twee sensoren aanwezig is. Dit duidt er 
op dat Syt1 en Syt7 fusie regelen van dezelfde DCVs, in dezelfde ‘pathway’. Hoewel 
beide sensoren nodig zijn, kunnen ze tóch elkaars functie overnemen, zolang er 
maar veel van één soort aanwezig is. Daarnaast laat ik zien dat overexpressie van 
beide Synaptotagmins zorgt voor méér DCV-fusie, wat er op wijst dat het aantal 
Syt-moleculen beperkend (rate-limiting) is voor DCV-fusie. Zoals verwacht kunnen 
sensoren waarvan de Ca2+-bindende domeinen gemuteerd zijn (ze kunnen dus geen 
Ca2+ meer binden) geen vesiclefusie triggeren. Als laatste laat ik zien dat Syt1 en 
Syt7 niet specifiek ‘snelle’ of ‘langzame’ DCV-fusie regelen, in tegenstelling tot wat 








Figuur 1: cartoon van een neuron met een zoom-in van twee dense-core vesicles: één gevuld met 
neuropeptiden (boven), en één dense-core vesicle die fuseert met de plasma membraan (onder), 
waardoor neuropeptiden worden afgegeven.
Samenvatting 119
8
DCV fusie regelen in dezelfde pathway, en dat het aantal Syt-moleculen bepalend is 
voor de efficiëntie daarvan.
In hoofdstuk 3 laat ik zien dat beide calciumsensoren op verschillende plekken 
in de hersencel aanwezig zijn. Synaptotagmin-1 zit op DCVs, zowel op fuserende 
als op bewegende, niet-fuserende DCVs. Synaptotagmin-7 zit veel minder op DCVs, 
maar is daarentegen meer aanwezig op de plasmamembraan van de hersencel. 
Daarnaast is Syt7 veel aanwezig op lysosomen, de afvalverwerkers van de cel. Syt1 
en Syt7 zijn dus aanwezig in verschillende compartimenten, en ondersteunen/
regelen DCV-fusie waarschijnlijk vanaf verschillende locaties in het neuron.
Hoofdstuk 4 gaat dieper in op de eigenschappen van fuserende dense-core 
vesicles en rapporteert dat Syt1 and Syt7 een verschillende invloed hebben op 
de duur van fuserende DCVs (fusie events). Synaptotagmin-1 zorgt ervoor dat 
fusie-events lang aan de membraan blijven zitten: wanneer Syt1 niet aanwezig is, 
duurt een fusie-event korter, en een fusie-event duurt juist langer wanneer Syt1 
tot overexpressie wordt gebracht. Dit betekent waarschijnlijk dat Synaptotagmin-1 
voor stabiliteit zorgt (van de ‘fusie pore’) van het fuserende vesicle aan de plasma 
membraan. Synaptotagmin-7 daarentegen had geen invloed op de duur van fu-
sie-events.
In hoofdstuk 5 worden de bevindingen samengevat en bediscussieerd en doe 
ik verschillende suggesties over de werkingsmechanismen van Syts in DCV-fusie. 
Dit proefschrift geeft nieuwe inzichten in hoe Ca2+ de afgifte van neuropeptiden 
reguleert en identificeert twee Ca2+-sensoren, Syt1 en Syt7, die nodig zijn voor de 
fusie van DCVs. Daarnaast laat ik zien dat DCV-fusie in bepaalde aspecten verschilt 
van de afgifte van neurotransmitters en neuro-endocriene signaalstoffen. Al met al 
draagt deze thesis bij aan het begrip van fundamentele moleculaire mechanismen 
van neuropeptide-gemedieerde signaaloverdacht in het brein.
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hering to the rules of scientific writing, the text in this thesis has been meticulously 
stripped from all emotional load. You will therefore not read sentences like ‘manual 
detection of DCV fusion events (a.k.a. ‘clicking’) was a near-RSI experience, but was 
kept in the doable range thanks to the continuous supply of podcasts, TED-talks, 
and documentaries’, but instead find it formulated as ‘3 x 3 pixel ROIs were manually 
placed using ImageJ’. This way of formulation supports readability and objectivity, 
although most scientists will acknowledge that research is a continuous oscillation 
between success and failure. To the researcher the task to come up with new experi-
ments to flip the balance to the first. One of many things I learned during a PhD, 
is that the prerequisite for finishing a PhD lies in successful mood management. 
This thesis would not have been possible without the support of others. Therefore, 
I would like to thank everyone who has been on my side and contributed to the 
success of this intense and wonderful life experience.
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